{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cancer drug targeting", "hepatocellular carcinoma", "liver cancer", "nanomedicines", "nanoparticles", "phytochemicals", "plant bioactives", "preclinical trials", "tumor microenvironment"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37376061", "DateRevised": {"Year": "2023", "Month": "07", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "05", "Day": "29"}], "Language": ["eng"], "ELocationID": ["1611", "10.3390/pharmaceutics15061611"], "Journal": {"ISSN": "1999-4923", "JournalIssue": {"Volume": "15", "Issue": "6", "PubDate": {"Year": "2023", "Month": "May", "Day": "29"}}, "Title": "Pharmaceutics", "ISOAbbreviation": "Pharmaceutics"}, "ArticleTitle": "Critical Review in Designing Plant-Based Anticancer Nanoparticles against Hepatocellular Carcinoma.", "Abstract": {"AbstractText": ["Hepatocellular carcinoma (HCC), accounting for 85% of liver cancer cases, continues to be the third leading cause of cancer-related deaths worldwide. Although various forms of chemotherapy and immunotherapy have been investigated in clinics, patients continue to suffer from high toxicity and undesirable side effects. Medicinal plants contain novel critical bioactives that can target multimodal oncogenic pathways; however, their clinical translation is often challenged due to poor aqueous solubility, low cellular uptake, and poor bioavailability. Nanoparticle-based drug delivery presents great opportunities in HCC therapy by increasing selectivity and transferring sufficient doses of bioactives to tumor areas with minimal damage to adjacent healthy cells. In fact, many phytochemicals encapsulated in FDA-approved nanocarriers have demonstrated the ability to modulate the tumor microenvironment. In this review, information about the mechanisms of promising plant bioactives against HCC is discussed and compared. Their benefits and risks as future nanotherapeutics are underscored. Nanocarriers that have been employed to encapsulate both pure bioactives and crude extracts for application in various HCC models are examined and compared. Finally, the current limitations in nanocarrier design, challenges related to the HCC microenvironment, and future opportunities are also discussed for the clinical translation of plant-based nanomedicines from bench to bedside."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Pharmacy, Mahidol University, 447 Sri-Ayutthaya Rd., Rajathevi, Bangkok 10400, Thailand."}], "LastName": "Basu", "ForeName": "Aalok", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Pharmacy, Mahidol University, 447 Sri-Ayutthaya Rd., Rajathevi, Bangkok 10400, Thailand."}], "LastName": "Namporn", "ForeName": "Thanaphon", "Initials": "T"}, {"Identifier": ["0000-0002-4345-9159"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Pharmacy, Mahidol University, 447 Sri-Ayutthaya Rd., Rajathevi, Bangkok 10400, Thailand."}], "LastName": "Ruenraroengsak", "ForeName": "Pakatip", "Initials": "P"}], "GrantList": [{"GrantID": "Basic Research fund: fiscal year 2022, grant number BRF1-037/2565", "Agency": "Thailand Science Research and Innovation through Mahidol University", "Country": ""}, {"GrantID": "the International Postdoctoral Fellowship (fiscal year 2022).", "Agency": "Mahidol University", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceutics", "NlmUniqueID": "101534003", "ISSNLinking": "1999-4923"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209\u2013249. doi: 10.3322/caac.21660.", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Zhou L., Zhang M., Chen S. Comparison of Surgical Resection and Transcatheter Arterial Chemoembolization for Large Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Ann. Hepatol. 2023;28:100890. doi: 10.1016/j.aohep.2022.100890.", "ArticleIdList": ["10.1016/j.aohep.2022.100890", "36574929"]}, {"Citation": "De Minicis S., Marzioni M., Benedetti A., Svegliati-Baroni G. New Insights in Hepatocellular Carcinoma: From Bench to Bedside. Ann. Transl. Med. 2013;1:15. doi: 10.3978/j.issn.2305-5839.2013.01.06.", "ArticleIdList": ["10.3978/j.issn.2305-5839.2013.01.06", "PMC4200632", "25332959"]}, {"Citation": "Parikh S., Hyman D. Hepatocellular Cancer: A Guide for the Internist. Am. J. Med. 2007;120:194\u2013202. doi: 10.1016/j.amjmed.2006.11.020.", "ArticleIdList": ["10.1016/j.amjmed.2006.11.020", "17349437"]}, {"Citation": "Yang J.D., Hainaut P., Gores G.J., Amadou A., Plymoth A., Roberts L.R. A Global View of Hepatocellular Carcinoma: Trends, Risk, Prevention and Management. Nat. Rev. Gastroenterol. Hepatol. 2019;16:589\u2013604. doi: 10.1038/s41575-019-0186-y.", "ArticleIdList": ["10.1038/s41575-019-0186-y", "PMC6813818", "31439937"]}, {"Citation": "Siegel A.B., Zhu A.X. Metabolic Syndrome and Hepatocellular Carcinoma. Cancer. 2009;115:5651\u20135661. doi: 10.1002/cncr.24687.", "ArticleIdList": ["10.1002/cncr.24687", "PMC3397779", "19834957"]}, {"Citation": "Fan J.-G., Farrell G.C. Prevention of Hepatocellular Carcinoma in Nonviral-Related Liver Diseases. J. Gastroenterol. Hepatol. 2009;24:712\u2013719. doi: 10.1111/j.1440-1746.2009.05776.x.", "ArticleIdList": ["10.1111/j.1440-1746.2009.05776.x", "19646014"]}, {"Citation": "Ogunwobi O.O., Harricharran T., Huaman J., Galuza A., Odumuwagun O., Tan Y., Ma G.X., Nguyen M.T. Mechanisms of Hepatocellular Carcinoma Progression. World J. Gastroenterol. 2019;25:2279\u20132293. doi: 10.3748/wjg.v25.i19.2279.", "ArticleIdList": ["10.3748/wjg.v25.i19.2279", "PMC6529884", "31148900"]}, {"Citation": "Kudo M. Early Hepatocellular Carcinoma: Definition and Diagnosis. Liver Cancer. 2013;2:69\u201372. doi: 10.1159/000343842.", "ArticleIdList": ["10.1159/000343842", "PMC3740734", "24159598"]}, {"Citation": "Sacco R., Tapete G., Simonetti N., Sellitri R., Natali V., Melissari S., Cabibbo G., Biscaglia L., Bresci G., Giacomelli L. Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: A Review. J. Hepatocell. Carcinoma. 2017;4:105\u2013110. doi: 10.2147/JHC.S103661.", "ArticleIdList": ["10.2147/JHC.S103661", "PMC5538681", "28795053"]}, {"Citation": "Lang L. FDA Approves Sorafenib for Patients with Inoperable Liver Cancer. Gastroenterology. 2008;134:379. doi: 10.1053/j.gastro.2007.12.037.", "ArticleIdList": ["10.1053/j.gastro.2007.12.037", "18242200"]}, {"Citation": "Llovet J.M., Ricci S., Mazzaferro V., Hilgard P., Gane E., Blanc J.-F., de Oliveira A.C., Santoro A., Raoul J.-L., Forner A., et al. Sorafenib in Advanced Hepatocellular Carcinoma. N. Engl. J. Med. 2008;359:378\u2013390. doi: 10.1056/NEJMoa0708857.", "ArticleIdList": ["10.1056/NEJMoa0708857", "18650514"]}, {"Citation": "Cheng A.-L., Kang Y.-K., Chen Z., Tsao C.-J., Qin S., Kim J.S., Luo R., Feng J., Ye S., Yang T.-S., et al. Efficacy and Safety of Sorafenib in Patients in the Asia-Pacific Region with Advanced Hepatocellular Carcinoma: A Phase III Randomised, Double-Blind, Placebo-Controlled Trial. Lancet Oncol. 2009;10:25\u201334. doi: 10.1016/S1470-2045(08)70285-7.", "ArticleIdList": ["10.1016/S1470-2045(08)70285-7", "19095497"]}, {"Citation": "Nault J.-C., Galle P.R., Marquardt J.U. The Role of Molecular Enrichment on Future Therapies in Hepatocellular Carcinoma. J. Hepatol. 2018;69:237\u2013247. doi: 10.1016/j.jhep.2018.02.016.", "ArticleIdList": ["10.1016/j.jhep.2018.02.016", "29505843"]}, {"Citation": "Dyhl-Polk A., Mikkelsen M.K., Ladekarl M., Nielsen D.L. Clinical Trials of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma. J. Clin. Med. 2021;10:2662. doi: 10.3390/jcm10122662.", "ArticleIdList": ["10.3390/jcm10122662", "PMC8234948", "34208788"]}, {"Citation": "Luo X.-Y., Wu K.-M., He X.-X. Advances in Drug Development for Hepatocellular Carcinoma: Clinical Trials and Potential Therapeutic Targets. J. Exp. Clin. Cancer Res. 2021;40:172. doi: 10.1186/s13046-021-01968-w.", "ArticleIdList": ["10.1186/s13046-021-01968-w", "PMC8130401", "34006331"]}, {"Citation": "Rizzo A., Dadduzio V., Ricci A.D., Massari F., Di Federico A., Gadaleta-Caldarola G., Brandi G. Lenvatinib plus Pembrolizumab: The next Frontier for the Treatment of Hepatocellular Carcinoma? Expert Opin. Investig. Drugs. 2022;31:371\u2013378. doi: 10.1080/13543784.2021.1948532.", "ArticleIdList": ["10.1080/13543784.2021.1948532", "34167433"]}, {"Citation": "Wege H., Li J., Ittrich H. Treatment Lines in Hepatocellular Carcinoma. Visc. Med. 2019;35:266\u2013272. doi: 10.1159/000501749.", "ArticleIdList": ["10.1159/000501749", "PMC6738173", "31602390"]}, {"Citation": "Tella S.H., Kommalapati A., Mahipal A., Jin Z. First-Line Targeted Therapy for Hepatocellular Carcinoma: Role of Atezolizumab/Bevacizumab Combination. Biomedicines. 2022;10:1304. doi: 10.3390/biomedicines10061304.", "ArticleIdList": ["10.3390/biomedicines10061304", "PMC9220769", "35740326"]}, {"Citation": "Llovet J.M., Di Bisceglie A.M., Bruix J., Kramer B.S., Lencioni R., Zhu A.X., Sherman M., Schwartz M., Lotze M., Talwalkar J., et al. Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma. JNCI J. Natl. Cancer Inst. 2008;100:698\u2013711. doi: 10.1093/jnci/djn134.", "ArticleIdList": ["10.1093/jnci/djn134", "18477802"]}, {"Citation": "Bruix J., Takayama T., Mazzaferro V., Chau G.-Y., Yang J., Kudo M., Cai J., Poon R.T., Han K.-H., Tak W.Y., et al. Adjuvant Sorafenib for Hepatocellular Carcinoma after Resection or Ablation (STORM): A Phase 3, Randomised, Double-Blind, Placebo-Controlled Trial. Lancet Oncol. 2015;16:1344\u20131354. doi: 10.1016/S1470-2045(15)00198-9.", "ArticleIdList": ["10.1016/S1470-2045(15)00198-9", "26361969"]}, {"Citation": "Cui T., Liu Y., Wang J., Liu L. Adverse Effects of Immune-Checkpoint Inhibitors in Hepatocellular Carcinoma. OncoTargets Ther. 2020;13:11725\u201311740. doi: 10.2147/OTT.S279858.", "ArticleIdList": ["10.2147/OTT.S279858", "PMC7678689", "33235462"]}, {"Citation": "Abotaleb M., Liskova A., Kubatka P., B\u00fcsselberg D. Therapeutic Potential of Plant Phenolic Acids in the Treatment of Cancer. Biomolecules. 2020;10:221. doi: 10.3390/biom10020221.", "ArticleIdList": ["10.3390/biom10020221", "PMC7072661", "32028623"]}, {"Citation": "Hegazy M.-E.F., Abdelfatah S., Hamed A.R., Mohamed T.A., Elshamy A.A., Saleh I.A., Reda E.H., Abdel-Azim N.S., Shams K.A., Sakr M., et al. Cytotoxicity of 40 Egyptian Plant Extracts Targeting Mechanisms of Drug-Resistant Cancer Cells. Phytomedicine. 2019;59:152771. doi: 10.1016/j.phymed.2018.11.031.", "ArticleIdList": ["10.1016/j.phymed.2018.11.031", "31055230"]}, {"Citation": "Dai R., Liu M., Xiang X., Li Y., Xi Z., Xu H. OMICS Applications for Medicinal Plants in Gastrointestinal Cancers: Current Advancements and Future Perspectives. Front. Pharmacol. 2022;13:842203. doi: 10.3389/fphar.2022.842203.", "ArticleIdList": ["10.3389/fphar.2022.842203", "PMC8855055", "35185591"]}, {"Citation": "McClements D.J. Advances in Nanoparticle and Microparticle Delivery Systems for Increasing the Dispersibility, Stability, and Bioactivity of Phytochemicals. Biotechnol. Adv. 2020;38:107287. doi: 10.1016/j.biotechadv.2018.08.004.", "ArticleIdList": ["10.1016/j.biotechadv.2018.08.004", "30086329"]}, {"Citation": "Kumar P., Yadav N., Chaudhary B., Jain V., Balaramnavar V.M., Alharbi K.S., Alenezi S.K., Al-Malki W.H., Ghoneim M.M., Alshehri S., et al. Promises of Phytochemical Based Nano Drug Delivery Systems in the Management of Cancer. Chem. Biol. Interact. 2022;351:109745. doi: 10.1016/j.cbi.2021.109745.", "ArticleIdList": ["10.1016/j.cbi.2021.109745", "34774839"]}, {"Citation": "Zhou Z., Xu M.-J., Gao B. Hepatocytes: A Key Cell Type for Innate Immunity. Cell. Mol. Immunol. 2016;13:301\u2013315. doi: 10.1038/cmi.2015.97.", "ArticleIdList": ["10.1038/cmi.2015.97", "PMC4856808", "26685902"]}, {"Citation": "Cabrera R., Nelson D.R. Review Article: The Management of Hepatocellular Carcinoma. Aliment. Pharmacol. Ther. 2010;31:461\u2013476. doi: 10.1111/j.1365-2036.2009.04200.x.", "ArticleIdList": ["10.1111/j.1365-2036.2009.04200.x", "19925500"]}, {"Citation": "Hu M., Wang Y., Xu L., An S., Tang Y., Zhou X., Li J., Liu R., Huang L. Relaxin Gene Delivery Mitigates Liver Metastasis and Synergizes with Check Point Therapy. Nat. Commun. 2019;10:2993. doi: 10.1038/s41467-019-10893-8.", "ArticleIdList": ["10.1038/s41467-019-10893-8", "PMC6611764", "31278269"]}, {"Citation": "Schulze K., Imbeaud S., Letouz\u00e9 E., Alexandrov L.B., Calderaro J., Rebouissou S., Couchy G., Meiller C., Shinde J., Soysouvanh F., et al. Exome Sequencing of Hepatocellular Carcinomas Identifies New Mutational Signatures and Potential Therapeutic Targets. Nat. Genet. 2015;47:505\u2013511. doi: 10.1038/ng.3252.", "ArticleIdList": ["10.1038/ng.3252", "PMC4587544", "25822088"]}, {"Citation": "Jiang Y., Sun A., Zhao Y., Ying W., Sun H., Yang X., Xing B., Sun W., Ren L., Hu B., et al. Proteomics Identifies New Therapeutic Targets of Early-Stage Hepatocellular Carcinoma. Nature. 2019;567:257\u2013261. doi: 10.1038/s41586-019-0987-8.", "ArticleIdList": ["10.1038/s41586-019-0987-8", "30814741"]}, {"Citation": "Chen Z., Jiang L., Liang L., Koral K., Zhang Q., Zhao L., Lu S., Tao J. The Role of Fibroblast Growth Factor 19 in Hepatocellular Carcinoma. Am. J. Pathol. 2021;191:1180\u20131192. doi: 10.1016/j.ajpath.2021.04.014.", "ArticleIdList": ["10.1016/j.ajpath.2021.04.014", "PMC8351122", "34000282"]}, {"Citation": "Wang J., Zheng C., Zhai Y., Cai Y., Lee R.J., Xing J., Wang H., Zhu H.H., Teng L., Li Y., et al. High-Density Lipoprotein Modulates Tumor-Associated Macrophage for Chemoimmunotherapy of Hepatocellular Carcinoma. Nano Today. 2021;37:101064. doi: 10.1016/j.nantod.2020.101064.", "ArticleIdList": ["10.1016/j.nantod.2020.101064"]}, {"Citation": "Cai H., Yang Y., Peng F., Liu Y., Fu X., Ji B. Gold Nanoparticles-Loaded Anti-MiR221 Enhances Antitumor Effect of Sorafenib in Hepatocellular Carcinoma Cells. Int. J. Med. Sci. 2019;16:1541\u20131548. doi: 10.7150/ijms.37427.", "ArticleIdList": ["10.7150/ijms.37427", "PMC6909811", "31839741"]}, {"Citation": "Song Y., Kim S., Kim K.M., Choi E.K., Kim J., Seo H.R. Activated Hepatic Stellate Cells Play Pivotal Roles in Hepatocellular Carcinoma Cell Chemoresistance and Migration in Multicellular Tumor Spheroids. Sci. Rep. 2016;6:36750. doi: 10.1038/srep36750.", "ArticleIdList": ["10.1038/srep36750", "PMC5113076", "27853186"]}, {"Citation": "Khan A.R., Yang X., Du X., Yang H., Liu Y., Khan A.Q., Zhai G. Chondroitin Sulfate Derived Theranostic and Therapeutic Nanocarriers for Tumor-Targeted Drug Delivery. Carbohydr. Polym. 2020;233:115837. doi: 10.1016/j.carbpol.2020.115837.", "ArticleIdList": ["10.1016/j.carbpol.2020.115837", "32059890"]}, {"Citation": "Zhang M., Xu N., Xu W., Ling G., Zhang P. Potential Therapies and Diagnosis Based on Golgi-Targeted Nano Drug Delivery Systems. Pharmacol. Res. 2022;175:105861. doi: 10.1016/j.phrs.2021.105861.", "ArticleIdList": ["10.1016/j.phrs.2021.105861", "34464677"]}, {"Citation": "Subhan M.A., Yalamarty S.S.K., Filipczak N., Parveen F., Torchilin V.P. Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment. J. Pers. Med. 2021;11:571. doi: 10.3390/jpm11060571.", "ArticleIdList": ["10.3390/jpm11060571", "PMC8234032", "34207137"]}, {"Citation": "Matsumura Y., Maeda H. A New Concept for Macromolecular Therapeutics in Cancer Chemotherapy: Mechanism of Tumoritropic Accumulation of Proteins and the Antitumor Agent Smancs. Cancer Res. 1986;46:6387\u20136392.", "ArticleIdList": ["2946403"]}, {"Citation": "Zhang A., Miao K., Sun H., Deng C.-X. Tumor Heterogeneity Reshapes the Tumor Microenvironment to Influence Drug Resistance. Int. J. Biol. Sci. 2022;18:3019\u20133033. doi: 10.7150/ijbs.72534.", "ArticleIdList": ["10.7150/ijbs.72534", "PMC9066118", "35541919"]}, {"Citation": "Craig A.J., von Felden J., Garcia-Lezana T., Sarcognato S., Villanueva A. Tumour Evolution in Hepatocellular Carcinoma. Nat. Rev. Gastroenterol. Hepatol. 2020;17:139\u2013152. doi: 10.1038/s41575-019-0229-4.", "ArticleIdList": ["10.1038/s41575-019-0229-4", "31792430"]}, {"Citation": "Lu L.-C., Hsu C.-H., Hsu C., Cheng A.-L. Tumor Heterogeneity in Hepatocellular Carcinoma: Facing the Challenges. Liver Cancer. 2016;5:128\u2013138. doi: 10.1159/000367754.", "ArticleIdList": ["10.1159/000367754", "PMC4906428", "27386431"]}, {"Citation": "Dagogo-Jack I., Shaw A.T. Tumour Heterogeneity and Resistance to Cancer Therapies. Nat. Rev. Clin. Oncol. 2018;15:81\u201394. doi: 10.1038/nrclinonc.2017.166.", "ArticleIdList": ["10.1038/nrclinonc.2017.166", "29115304"]}, {"Citation": "D\u2019Souza A.A., Devarajan P.V. Asialoglycoprotein Receptor Mediated Hepatocyte Targeting\u2014Strategies and Applications. J. Control. Release. 2015;203:126\u2013139. doi: 10.1016/j.jconrel.2015.02.022.", "ArticleIdList": ["10.1016/j.jconrel.2015.02.022", "25701309"]}, {"Citation": "Calzolari A., Oliviero I., Deaglio S., Mariani G., Biffoni M., Sposi N.M., Malavasi F., Peschle C., Testa U. Transferrin Receptor 2 Is Frequently Expressed in Human Cancer Cell Lines. Blood Cells Mol. Dis. 2007;39:82\u201391. doi: 10.1016/j.bcmd.2007.02.003.", "ArticleIdList": ["10.1016/j.bcmd.2007.02.003", "17428703"]}, {"Citation": "Pang H.-B., Braun G.B., Ruoslahti E. Neuropilin-1 and Heparan Sulfate Proteoglycans Cooperate in Cellular Uptake of Nanoparticles Functionalized by Cationic Cell-Penetrating Peptides. Sci. Adv. 2015;1:e1500821. doi: 10.1126/sciadv.1500821.", "ArticleIdList": ["10.1126/sciadv.1500821", "PMC4640594", "26601141"]}, {"Citation": "Ahmed M., Narain R. Carbohydrate-Based Materials for Targeted Delivery of Drugs and Genes to the Liver. Nanomedicine. 2015;10:2263\u20132288. doi: 10.2217/nnm.15.58.", "ArticleIdList": ["10.2217/nnm.15.58", "26214359"]}, {"Citation": "B\u00f6ttger R., Pauli G., Chao P.-H., AL Fayez N., Hohenwarter L., Li S.-D. Lipid-Based Nanoparticle Technologies for Liver Targeting. Adv. Drug Deliv. Rev. 2020;154\u2013155:79\u2013101. doi: 10.1016/j.addr.2020.06.017.", "ArticleIdList": ["10.1016/j.addr.2020.06.017", "32574575"]}, {"Citation": "Wang H., Thorling C.A., Liang X., Bridle K.R., Grice J.E., Zhu Y., Crawford D.H.G., Xu Z.P., Liu X., Roberts M.S. Diagnostic Imaging and Therapeutic Application of Nanoparticles Targeting the Liver. J. Mater. Chem. B. 2015;3:939\u2013958. doi: 10.1039/C4TB01611D.", "ArticleIdList": ["10.1039/C4TB01611D", "32261972"]}, {"Citation": "Marquez J., Fernandez-Pi\u00f1eiro I., Ara\u00fazo-Bravo M.J., Poschmann G., St\u00fchler K., Khatib A.-M., Sanchez A., Unda F., Ibarretxe G., Bernales I., et al. Targeting Liver Sinusoidal Endothelial Cells with MiR-20a-Loaded Nanoparticles Reduces Murine Colon Cancer Metastasis to the Liver. Int. J. Cancer. 2018;143:709\u2013719. doi: 10.1002/ijc.31343.", "ArticleIdList": ["10.1002/ijc.31343", "29492958"]}, {"Citation": "Arechederra M., Bazai S.K., Abdouni A., Sequera C., Mead T.J., Richelme S., Daian F., Audebert S., Dono R., Lozano A., et al. ADAMTSL5 Is an Epigenetically Activated Gene Underlying Tumorigenesis and Drug Resistance in Hepatocellular Carcinoma. J. Hepatol. 2021;74:893\u2013906. doi: 10.1016/j.jhep.2020.11.008.", "ArticleIdList": ["10.1016/j.jhep.2020.11.008", "33197513"]}, {"Citation": "Fern\u00e1ndez-Barrena M.G., Arechederra M., Colyn L., Berasain C., Avila M.A. Epigenetics in Hepatocellular Carcinoma Development and Therapy: The Tip of the Iceberg. JHEP Rep. 2020;2:100167. doi: 10.1016/j.jhepr.2020.100167.", "ArticleIdList": ["10.1016/j.jhepr.2020.100167", "PMC7585149", "33134907"]}, {"Citation": "Tacke F. Targeting Hepatic Macrophages to Treat Liver Diseases. J. Hepatol. 2017;66:1300\u20131312. doi: 10.1016/j.jhep.2017.02.026.", "ArticleIdList": ["10.1016/j.jhep.2017.02.026", "28267621"]}, {"Citation": "Kaps L., Schuppan D. Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers. Cells. 2020;9:2027. doi: 10.3390/cells9092027.", "ArticleIdList": ["10.3390/cells9092027", "PMC7563527", "32899119"]}, {"Citation": "Bonferoni M.C., Gavini E., Rassu G., Maestri M., Giunchedi P. Chitosan Nanoparticles for Therapy and Theranostics of Hepatocellular Carcinoma (HCC) and Liver-Targeting. Nanomaterials. 2020;10:870. doi: 10.3390/nano10050870.", "ArticleIdList": ["10.3390/nano10050870", "PMC7279387", "32365938"]}, {"Citation": "Zein R., Sharrouf W., Selting K. Physical Properties of Nanoparticles That Result in Improved Cancer Targeting. J. Oncol. 2020;2020:1\u201316. doi: 10.1155/2020/5194780.", "ArticleIdList": ["10.1155/2020/5194780", "PMC7374236", "32765604"]}, {"Citation": "Ernsting M.J., Murakami M., Roy A., Li S.-D. Factors Controlling the Pharmacokinetics, Biodistribution and Intratumoral Penetration of Nanoparticles. J. Control. Release. 2013;172:782\u2013794. doi: 10.1016/j.jconrel.2013.09.013.", "ArticleIdList": ["10.1016/j.jconrel.2013.09.013", "PMC3891171", "24075927"]}, {"Citation": "Lombardo S.M., Schneider M., T\u00fcreli A.E., G\u00fcnday T\u00fcreli N. Key for Crossing the BBB with Nanoparticles: The Rational Design. Beilstein J. Nanotechnol. 2020;11:866\u2013883. doi: 10.3762/bjnano.11.72.", "ArticleIdList": ["10.3762/bjnano.11.72", "PMC7277618", "32551212"]}, {"Citation": "Miyazawa T., Itaya M., Burdeos G.C., Nakagawa K., Miyazawa T. A Critical Review of the Use of Surfactant-Coated Nanoparticles in Nanomedicine and Food Nanotechnology. Int. J. Nanomed. 2021;16:3937\u20133999. doi: 10.2147/IJN.S298606.", "ArticleIdList": ["10.2147/IJN.S298606", "PMC8203100", "34140768"]}, {"Citation": "Abdellatif A.A.H., Aldalaen S.M., Faisal W., Tawfeek H.M. Somatostatin Receptors as a New Active Targeting Sites for Nanoparticles. Saudi Pharm. J. 2018;26:1051\u20131059. doi: 10.1016/j.jsps.2018.05.014.", "ArticleIdList": ["10.1016/j.jsps.2018.05.014", "PMC6218373", "30416362"]}, {"Citation": "Kira S., Nakanishi T., Suemori S., Kitamoto M., Watanabe Y., Kajiyama G. Expression of Transforming Growth Factor Alpha and Epidermal Growth Factor Receptor in Human Hepatocellular Carcinoma. Liver. 2008;17:177\u2013182. doi: 10.1111/j.1600-0676.1997.tb00803.x.", "ArticleIdList": ["10.1111/j.1600-0676.1997.tb00803.x", "9298487"]}, {"Citation": "Zhai J., Scoble J.A., Li N., Lovrecz G., Waddington L.J., Tran N., Muir B.W., Coia G., Kirby N., Drummond C.J., et al. Epidermal Growth Factor Receptor-Targeted Lipid Nanoparticles Retain Self-Assembled Nanostructures and Provide High Specificity. Nanoscale. 2015;7:2905\u20132913. doi: 10.1039/C4NR05200E.", "ArticleIdList": ["10.1039/C4NR05200E", "25516406"]}, {"Citation": "Da Silva Santos E., Nogueira K.A.B., Fernandes L.C.C., Martins J.R.P., Reis A.V.F., Neto J.D.B.V., da Silva J\u00fanior I.J., Pessoa C., Petrilli R., Eloy J.O. EGFR Targeting for Cancer Therapy: Pharmacology and Immunoconjugates with Drugs and Nanoparticles. Int. J. Pharm. 2021;592:120082. doi: 10.1016/j.ijpharm.2020.120082.", "ArticleIdList": ["10.1016/j.ijpharm.2020.120082", "33188892"]}, {"Citation": "Singh V.K., Chau E., Mishra A., DeAnda A., Hegde V.L., Sastry J.K., Haviland D., Jagannath C., Godin B., Khan A. CD44 Receptor Targeted Nanoparticles Augment Immunity against Tuberculosis in Mice. J. Control. Release. 2022;349:796\u2013811. doi: 10.1016/j.jconrel.2022.07.040.", "ArticleIdList": ["10.1016/j.jconrel.2022.07.040", "PMC10478167", "35914613"]}, {"Citation": "Wang L., Su W., Liu Z., Zhou M., Chen S., Chen Y., Lu D., Liu Y., Fan Y., Zheng Y., et al. CD44 Antibody-Targeted Liposomal Nanoparticles for Molecular Imaging and Therapy of Hepatocellular Carcinoma. Biomaterials. 2012;33:5107\u20135114. doi: 10.1016/j.biomaterials.2012.03.067.", "ArticleIdList": ["10.1016/j.biomaterials.2012.03.067", "22494888"]}, {"Citation": "Li Z., Zeng Y., Zhang D., Wu M., Wu L., Huang A., Yang H., Liu X., Liu J. Glypican-3 Antibody Functionalized Prussian Blue Nanoparticles for Targeted MR Imaging and Photothermal Therapy of Hepatocellular Carcinoma. J. Mater. Chem. B. 2014;2:3686\u20133696. doi: 10.1039/C4TB00516C.", "ArticleIdList": ["10.1039/C4TB00516C", "32263805"]}, {"Citation": "Gong T., Wang X., Ma Q., Li J., Li M., Huang Y., Liang W., Su D., Guo R. Triformyl Cholic Acid and Folic Acid Functionalized Magnetic Graphene Oxide Nanocomposites: Multiple-Targeted Dual-Modal Synergistic Chemotherapy/Photothermal Therapy for Liver Cancer. J. Inorg. Biochem. 2021;223:111558. doi: 10.1016/j.jinorgbio.2021.111558.", "ArticleIdList": ["10.1016/j.jinorgbio.2021.111558", "34329998"]}, {"Citation": "Wei Y., Gu X., Cheng L., Meng F., Storm G., Zhong Z. Low-Toxicity Transferrin-Guided Polymersomal Doxorubicin for Potent Chemotherapy of Orthotopic Hepatocellular Carcinoma in Vivo. Acta Biomater. 2019;92:196\u2013204. doi: 10.1016/j.actbio.2019.05.034.", "ArticleIdList": ["10.1016/j.actbio.2019.05.034", "31102765"]}, {"Citation": "Li X., Liu Y., Wu X., Gao Y., Zhang J., Zhang D., Gu S., Zhu G., Liu G. Aptamer-Functionalized Peptide H3CR5C as a Novel Nanovehicle for Codelivery of Fasudil and MiRNA-195 Targeting Hepatocellular Carcinoma. Int. J. Nanomed. 2016;11:3891\u20133905. doi: 10.2147/IJN.S108128.", "ArticleIdList": ["10.2147/IJN.S108128", "PMC4990390", "27574422"]}, {"Citation": "Lou S., Gao S., Wang W., Zhang M., Zhang J., Wang C., Li C., Kong D., Zhao Q. Galactose-Functionalized Multi-Responsive Nanogels for Hepatoma-Targeted Drug Delivery. Nanoscale. 2015;7:3137\u20133146. doi: 10.1039/C4NR06714B.", "ArticleIdList": ["10.1039/C4NR06714B", "25613320"]}, {"Citation": "Biscaglia F., Quarta S., Villano G., Turato C., Biasiolo A., Litti L., Ruzzene M., Meneghetti M., Pontisso P., Gobbo M. PreS1 Peptide-Functionalized Gold Nanostructures with SERRS Tags for Efficient Liver Cancer Cell Targeting. Mater. Sci. Eng. C. 2019;103:109762. doi: 10.1016/j.msec.2019.109762.", "ArticleIdList": ["10.1016/j.msec.2019.109762", "31349478"]}, {"Citation": "Lynch I., Dawson K.A. Protein-Nanoparticle Interactions. Nano Today. 2008;3:40\u201347. doi: 10.1016/S1748-0132(08)70014-8.", "ArticleIdList": ["10.1016/S1748-0132(08)70014-8"]}, {"Citation": "Yang S., Cai C., Wang H., Ma X., Shao A., Sheng J., Yu C. Drug Delivery Strategy in Hepatocellular Carcinoma Therapy. Cell Commun. Signal. 2022;20:26. doi: 10.1186/s12964-021-00796-x.", "ArticleIdList": ["10.1186/s12964-021-00796-x", "PMC8898478", "35248060"]}, {"Citation": "Fan W., Yung B., Huang P., Chen X. Nanotechnology for Multimodal Synergistic Cancer Therapy. Chem. Rev. 2017;117:13566\u201313638. doi: 10.1021/acs.chemrev.7b00258.", "ArticleIdList": ["10.1021/acs.chemrev.7b00258", "29048884"]}, {"Citation": "Chen H., Liu R.H. Potential Mechanisms of Action of Dietary Phytochemicals for Cancer Prevention by Targeting Cellular Signaling Transduction Pathways. J. Agric. Food Chem. 2018;66:3260\u20133276. doi: 10.1021/acs.jafc.7b04975.", "ArticleIdList": ["10.1021/acs.jafc.7b04975", "29498272"]}, {"Citation": "Mondal A., Guria T., Maity T., Bishayee A. A Novel Tetraenoic Fatty Acid Isolated from Amaranthus Spinosus Inhibits Proliferation and Induces Apoptosis of Human Liver Cancer Cells. Int. J. Mol. Sci. 2016;17:1604. doi: 10.3390/ijms17101604.", "ArticleIdList": ["10.3390/ijms17101604", "PMC5085637", "27669220"]}, {"Citation": "Malik Z., Parveen R., Parveen B., Zahiruddin S., Aasif Khan M., Khan A., Massey S., Ahmad S., Husain S.A. Anticancer Potential of Andrographolide from Andrographis Paniculata (Burm.f.) Nees and Its Mechanisms of Action. J. Ethnopharmacol. 2021;272:113936. doi: 10.1016/j.jep.2021.113936.", "ArticleIdList": ["10.1016/j.jep.2021.113936", "33610710"]}, {"Citation": "Chowdhury K.D., Sarkar A., Chatterjee S., Patra D., Sengupta D., Banerjee S., Chakraborty P., Sadhukhan G.C. Cathepsin B Mediated Scramblase Activation Triggers Cytotoxicity and Cell Cycle Arrest by Andrographolide to Overcome Cellular Resistance in Cisplatin Resistant Human Hepatocellular Carcinoma HepG2 Cells. Environ. Toxicol. Pharmacol. 2019;68:120\u2013132. doi: 10.1016/j.etap.2019.03.003.", "ArticleIdList": ["10.1016/j.etap.2019.03.003", "30889542"]}, {"Citation": "Dasgupta A., Dey D., Ghosh D., Lai T.K., Bhuvanesh N., Dolui S., Velayutham R., Acharya K. Astrakurkurone, a Sesquiterpenoid from Wild Edible Mushroom, Targets Liver Cancer Cells by Modulating Bcl-2 Family Proteins. IUBMB Life. 2019;71:992\u20131002. doi: 10.1002/iub.2047.", "ArticleIdList": ["10.1002/iub.2047", "30977280"]}, {"Citation": "Chu Y.-L., Ho C.-T., Chung J.-G., Raghu R., Lo Y.-C., Sheen L.-Y. Allicin Induces Anti-Human Liver Cancer Cells through the P53 Gene Modulating Apoptosis and Autophagy. J. Agric. Food Chem. 2013;61:9839\u20139848. doi: 10.1021/jf403241s.", "ArticleIdList": ["10.1021/jf403241s", "24059278"]}, {"Citation": "Lou L., Ye W., Chen Y., Wu S., Jin L., He J., Tao X., Zhu J., Chen X., Deng A., et al. Ardipusilloside Inhibits Survival, Invasion and Metastasis of Human Hepatocellular Carcinoma Cells. Phytomedicine. 2012;19:603\u2013608. doi: 10.1016/j.phymed.2012.01.003.", "ArticleIdList": ["10.1016/j.phymed.2012.01.003", "22349030"]}, {"Citation": "Jung K.H., Rumman M., Yan H., Cheon M.J., Choi J.G., Jin X., Park S., Oh M.S., Hong S.-S. An Ethyl Acetate Fraction of Artemisia Capillaris (ACE-63) Induced Apoptosis and Anti-Angiogenesis via Inhibition of PI3K/AKT Signaling in Hepatocellular Carcinoma. Phyther. Res. 2018;32:2034\u20132046. doi: 10.1002/ptr.6135.", "ArticleIdList": ["10.1002/ptr.6135", "29972254"]}, {"Citation": "Li M., Zhang M., Zhang Z., Liu N., Han X., Liu Q., Deng W., Liao C. Induction of Apoptosis by Berberine in Hepatocellular Carcinoma HepG2 Cells via Downregulation of NF-\u039aB. Oncol. Res. Featur. Preclin. Clin. Cancer Ther. 2017;25:233\u2013239. doi: 10.3727/096504016X14742891049073.", "ArticleIdList": ["10.3727/096504016X14742891049073", "PMC7840840", "28277195"]}, {"Citation": "Tong N., Zhang J., Chen Y., Li Z., Luo Y., Zuo H., Zhao X. Berberine Sensitizes Mutliple Human Cancer Cells to the Anticancer Effects of Doxorubicin in Vitro. Oncol. Lett. 2012;3:1263\u20131267. doi: 10.3892/ol.2012.644.", "ArticleIdList": ["10.3892/ol.2012.644", "PMC3392583", "22783430"]}, {"Citation": "Li Q., Li Y., Wang X., Fang X., He K., Guo X., Zhan Z., Sun C., Jin Y.-H. Co-Treatment with Ginsenoside Rh2 and Betulinic Acid Synergistically Induces Apoptosis in Human Cancer Cells in Association with Enhanced Capsase-8 Activation, Bax Translocation, and Cytochrome c Release. Mol. Carcinog. 2011;50:760\u2013769. doi: 10.1002/mc.20673.", "ArticleIdList": ["10.1002/mc.20673", "21751259"]}, {"Citation": "Liu W., Li S., Qu Z., Luo Y., Chen R., Wei S., Yang X., Wang Q. Betulinic Acid Induces Autophagy-Mediated Apoptosis through Suppression of the PI3K/AKT/MTOR Signaling Pathway and Inhibits Hepatocellular Carcinoma. Am. J. Transl. Res. 2019;11:6952.", "ArticleIdList": ["PMC6895530", "31814899"]}, {"Citation": "Noureini S.K., Wink M. Dose-Dependent Cytotoxic Effects of Boldine in HepG-2 Cells\u2014Telomerase Inhibition and Apoptosis Induction. Molecules. 2015;20:3730\u20133743. doi: 10.3390/molecules20033730.", "ArticleIdList": ["10.3390/molecules20033730", "PMC6272231", "25719742"]}, {"Citation": "Subramaniam N., Kannan P., Ashokkumar K., Thiruvengadam D. Hepatoprotective Effect of Boldine against Diethylnitrosamine-induced Hepatocarcinogenesis in Wistar Rats. J. Biochem. Mol. Toxicol. 2019;33:e22404. doi: 10.1002/jbt.22404.", "ArticleIdList": ["10.1002/jbt.22404", "31593341"]}, {"Citation": "Wang Z., Gu C., Wang X., Lang Y., Wu Y., Wu X., Zhu X., Wang K., Yang H. Caffeine Enhances the Anti-Tumor Effect of 5-Fluorouracil via Increasing the Production of Reactive Oxygen Species in Hepatocellular Carcinoma. Med. Oncol. 2019;36:97. doi: 10.1007/s12032-019-1323-8.", "ArticleIdList": ["10.1007/s12032-019-1323-8", "31664534"]}, {"Citation": "Bort A., Sp\u00ednola E., Rodr\u00edguez-Henche N., D\u00edaz-Laviada I. Capsaicin Exerts Synergistic Antitumor Effect with Sorafenib in Hepatocellular Carcinoma Cells through AMPK Activation. Oncotarget. 2017;8:87684\u201387698. doi: 10.18632/oncotarget.21196.", "ArticleIdList": ["10.18632/oncotarget.21196", "PMC5675664", "29152112"]}, {"Citation": "Lee Y.S., Kang Y.S., Lee J.-S., Nicolova S., Kim J.-A. Involvement of NADPH Oxidase-Mediated Generation of Reactive Oxygen Species in the Apototic Cell Death by Capsaicin in HepG2 Human Hepatoma Cells. Free Radic. Res. 2004;38:405\u2013412. doi: 10.1080/10715760410001665262.", "ArticleIdList": ["10.1080/10715760410001665262", "15190937"]}, {"Citation": "Zhang S., Ni Y., Zhao C., Qiao Z., Yu H., Wang L., Sun J., Du C., Zhang J., Dong L., et al. Capsaicin Enhances the Antitumor Activity of Sorafenib in Hepatocellular Carcinoma Cells and Mouse Xenograft Tumors through Increased ERK Signaling. Acta Pharmacol. Sin. 2018;39:438\u2013448. doi: 10.1038/aps.2017.156.", "ArticleIdList": ["10.1038/aps.2017.156", "PMC5843835", "29188798"]}, {"Citation": "Zhang X., Chen Y., Cai G., Li X., Wang D. Carnosic Acid Induces Apoptosis of Hepatocellular Carcinoma Cells via ROS-Mediated Mitochondrial Pathway. Chem. Biol. Interact. 2017;277:91\u2013100. doi: 10.1016/j.cbi.2017.09.005.", "ArticleIdList": ["10.1016/j.cbi.2017.09.005", "28918123"]}, {"Citation": "Yao C., Liu B.-B., Qian X.-D., Li L.-Q., Cao H.-B., Guo Q.-S., Zhou G.-F. Crocin Induces Autophagic Apoptosis in Hepatocellular Carcinoma by Inhibiting Akt/MTOR Activity. OncoTargets Ther. 2018;11:2017\u20132028. doi: 10.2147/OTT.S154586.", "ArticleIdList": ["10.2147/OTT.S154586", "PMC5898595", "29670377"]}, {"Citation": "Abouzied M.M.M., Eltahir H.M., Abdel Aziz M.A., Ahmed N.S., Abd El-Ghany A.A., Abd El-Aziz E.A., Abd El-Aziz H.O. Curcumin Ameliorate DENA-Induced HCC via Modulating TGF-\u03b2, AKT, and Caspase-3 Expression in Experimental Rat Model. Tumor Biol. 2015;36:1763\u20131771. doi: 10.1007/s13277-014-2778-z.", "ArticleIdList": ["10.1007/s13277-014-2778-z", "25519685"]}, {"Citation": "Marquardt J.U., Gomez-Quiroz L., Arreguin Camacho L.O., Pinna F., Lee Y.-H., Kitade M., Dom\u00ednguez M.P., Castven D., Breuhahn K., Conner E.A., et al. Curcumin Effectively Inhibits Oncogenic NF-\u039aB Signaling and Restrains Stemness Features in Liver Cancer. J. Hepatol. 2015;63:661\u2013669. doi: 10.1016/j.jhep.2015.04.018.", "ArticleIdList": ["10.1016/j.jhep.2015.04.018", "PMC4543531", "25937435"]}, {"Citation": "Garc\u00eda-Vilas J.A., Quesada A.R., Medina M.A. Damnacanthal, a Noni Anthraquinone, Inhibits c-Met and Is a Potent Antitumor Compound against Hep G2 Human Hepatocellular Carcinoma Cells. Sci. Rep. 2015;5:8021. doi: 10.1038/srep08021.", "ArticleIdList": ["10.1038/srep08021", "PMC4306130", "25620570"]}, {"Citation": "Delle Monache S., Sanit\u00e0 P., Trapasso E., Ursino M.R., Dugo P., Russo M., Ferlazzo N., Calapai G., Angelucci A., Navarra M. Mechanisms Underlying the Anti-Tumoral Effects of Citrus Bergamia Juice. PLoS ONE. 2013;8:e61484. doi: 10.1371/journal.pone.0061484.", "ArticleIdList": ["10.1371/journal.pone.0061484", "PMC3628853", "23613861"]}, {"Citation": "Zhang Y., Owusu L., Duan W., Jiang T., Zang S., Ahmed A., Xin Y. Anti-Metastatic and Differential Effects on Protein Expression of Epigallocatechin-3-Gallate in HCCLM6 Hepatocellular Carcinoma Cells. Int. J. Mol. Med. 2013;32:959\u2013964. doi: 10.3892/ijmm.2013.1446.", "ArticleIdList": ["10.3892/ijmm.2013.1446", "23863984"]}, {"Citation": "Chen J., Chen L., Lu T., Xie Y., Li C., Jia Z., Cao J. ER\u03b136 Is an Effective Target of Epigallocatechin-3-Gallate in Hepatocellular Carcinoma. Int. J. Clin. Exp. Pathol. 2019;12:3222\u20133234.", "ArticleIdList": ["PMC6949832", "31934166"]}, {"Citation": "Li S., Wu L., Feng J., Li J., Liu T., Zhang R., Xu S., Cheng K., Zhou Y., Zhou S., et al. In Vitro and in Vivo Study of Epigallocatechin-3-Gallate-Induced Apoptosis in Aerobic Glycolytic Hepatocellular Carcinoma Cells Involving Inhibition of Phosphofructokinase Activity. Sci. Rep. 2016;6:28479. doi: 10.1038/srep28479.", "ArticleIdList": ["10.1038/srep28479", "PMC4923908", "27349173"]}, {"Citation": "Hsu C.-M., Hsu Y.-A., Tsai Y., Shieh F.-K., Huang S.-H., Wan L., Tsai F.-J. Emodin Inhibits the Growth of Hepatoma Cells: Finding the Common Anti-Cancer Pathway Using Huh7, Hep3B, and HepG2 Cells. Biochem. Biophys. Res. Commun. 2010;392:473\u2013478. doi: 10.1016/j.bbrc.2009.10.153.", "ArticleIdList": ["10.1016/j.bbrc.2009.10.153", "19895793"]}, {"Citation": "Sundarraj K., Raghunath A., Panneerselvam L., Perumal E. Fisetin, a Phytopolyphenol, Targets Apoptotic and Necroptotic Cell Death in HepG2 Cells. BioFactors. 2020;46:118\u2013135. doi: 10.1002/biof.1577.", "ArticleIdList": ["10.1002/biof.1577", "31634424"]}, {"Citation": "Youns M., Abdel Halim Hegazy W. The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways. PLoS ONE. 2017;12:e0169335. doi: 10.1371/journal.pone.0169335.", "ArticleIdList": ["10.1371/journal.pone.0169335", "PMC5215656", "28052097"]}, {"Citation": "Gu Y. Genistein Inhibits Invasive Potential of Human Hepatocellular Carcinoma by Altering Cell Cycle, Apoptosis, and Angiogenesis. World J. Gastroenterol. 2005;11:6512. doi: 10.3748/wjg.v11.i41.6512.", "ArticleIdList": ["10.3748/wjg.v11.i41.6512", "PMC4355795", "16425425"]}, {"Citation": "Fang S.-C., Hsu C.-L., Lin H.-T., Yen G.-C. Anticancer Effects of Flavonoid Derivatives Isolated from Millettia Reticulata Benth in SK-Hep-1 Human Hepatocellular Carcinoma Cells. J. Agric. Food Chem. 2010;58:814\u2013820. doi: 10.1021/jf903216r.", "ArticleIdList": ["10.1021/jf903216r", "19994890"]}, {"Citation": "Shi Q., Shi X., Zuo G., Xiong W., Li H., Guo P., Wang F., Chen Y., Li J., Chen D.-L. Anticancer Effect of 20(S)-Ginsenoside Rh2 on HepG2 Liver Carcinoma Cells: Activating GSK-3\u03b2 and Degrading \u03b2-Catenin. Oncol. Rep. 2016;36:2059\u20132070. doi: 10.3892/or.2016.5033.", "ArticleIdList": ["10.3892/or.2016.5033", "27573179"]}, {"Citation": "Jiang F., Mu J., Wang X., Ye X., Si L., Ning S., Li Z., Li Y. The Repressive Effect of MiR-148a on TGF Beta-SMADs Signal Pathway Is Involved in the Glabridin-Induced Inhibition of the Cancer Stem Cells-Like Properties in Hepatocellular Carcinoma Cells. PLoS ONE. 2014;9:e96698. doi: 10.1371/journal.pone.0096698.", "ArticleIdList": ["10.1371/journal.pone.0096698", "PMC4013140", "24806207"]}, {"Citation": "Kapkoti D.S., Singh S., Alam S., Khan F., Luqman S., Bhakuni R.S. In Vitro Antiproliferative Activity of Glabridin Derivatives and Their In Silico Target Identification. Nat. Prod. Res. 2020;34:1735\u20131742. doi: 10.1080/14786419.2018.1530228.", "ArticleIdList": ["10.1080/14786419.2018.1530228", "30580626"]}, {"Citation": "Mylonis I., Lakka A., Tsakalof A., Simos G. The Dietary Flavonoid Kaempferol Effectively Inhibits HIF-1 Activity and Hepatoma Cancer Cell Viability under Hypoxic Conditions. Biochem. Biophys. Res. Commun. 2010;398:74\u201378. doi: 10.1016/j.bbrc.2010.06.038.", "ArticleIdList": ["10.1016/j.bbrc.2010.06.038", "20558139"]}, {"Citation": "Durmaz I., Guven E.B., Ersahin T., Ozturk M., Calis I., Cetin-Atalay R. Liver Cancer Cells Are Sensitive to Lanatoside C Induced Cell Death Independent of Their PTEN Status. Phytomedicine. 2016;23:42\u201351. doi: 10.1016/j.phymed.2015.11.012.", "ArticleIdList": ["10.1016/j.phymed.2015.11.012", "26902406"]}, {"Citation": "Seydi E., Salimi A., Rasekh H.R., Mohsenifar Z., Pourahmad J. Selective Cytotoxicity of Luteolin and Kaempferol on Cancerous Hepatocytes Obtained from Rat Model of Hepatocellular Carcinoma: Involvement of ROS-Mediated Mitochondrial Targeting. Nutr. Cancer. 2018;70:594\u2013604. doi: 10.1080/01635581.2018.1460679.", "ArticleIdList": ["10.1080/01635581.2018.1460679", "29693446"]}, {"Citation": "Xie D., Yuan P., Wang D., Jin H., Chen H. Effects of Naringin on the Expression of MiR-19b and Cell Apoptosis in Human Hepatocellular Carcinoma. Oncol. Lett. 2017;14:1455\u20131459. doi: 10.3892/ol.2017.6278.", "ArticleIdList": ["10.3892/ol.2017.6278", "PMC5529873", "28789364"]}, {"Citation": "Yoon J.-S., Kim H.-M., Yadunandam A.K., Kim N.-H., Jung H.-A., Choi J.-S., Kim C.-Y., Kim G.-D. Neferine Isolated from Nelumbo Nucifera Enhances Anti-Cancer Activities in Hep3B Cells: Molecular Mechanisms of Cell Cycle Arrest, ER Stress Induced Apoptosis and Anti-Angiogenic Response. Phytomedicine. 2013;20:1013\u20131022. doi: 10.1016/j.phymed.2013.03.024.", "ArticleIdList": ["10.1016/j.phymed.2013.03.024", "23746959"]}, {"Citation": "Law B.Y.K., Michelangeli F., Qu Y.Q., Xu S.-W., Han Y., Mok S.W.F., Dias I.R.D.S.R., Javed M.-H., Chan W.-K., Xue W.-W., et al. Neferine Induces Autophagy-Dependent Cell Death in Apoptosis-Resistant Cancers via Ryanodine Receptor and Ca2+-Dependent Mechanism. Sci. Rep. 2019;9:20034. doi: 10.1038/s41598-019-56675-6.", "ArticleIdList": ["10.1038/s41598-019-56675-6", "PMC6934498", "31882989"]}, {"Citation": "Shyu M.-H., Kao T.-C., Yen G.-C. Oleanolic Acid and Ursolic Acid Induce Apoptosis in HuH7 Human Hepatocellular Carcinoma Cells through a Mitochondrial-Dependent Pathway and Downregulation of XIAP. J. Agric. Food Chem. 2010;58:6110\u20136118. doi: 10.1021/jf100574j.", "ArticleIdList": ["10.1021/jf100574j", "20415421"]}, {"Citation": "Dai Q., Yin Q., Wei L., Zhou Y., Qiao C., Guo Y., Wang X., Ma S., Lu N. Oroxylin A Regulates Glucose Metabolism in Response to Hypoxic Stress with the Involvement of Hypoxia-Inducible Factor-1 in Human Hepatoma HepG2 Cells. Mol. Carcinog. 2016;55:1275\u20131289. doi: 10.1002/mc.22369.", "ArticleIdList": ["10.1002/mc.22369", "26259145"]}, {"Citation": "Yang L., Zhang X., Li K., Li A., Yang W., Yang R., Wang P., Zhao Z., Cui F., Qin Y., et al. Protopanaxadiol Inhibits Epithelial\u2013Mesenchymal Transition of Hepatocellular Carcinoma by Targeting STAT3 Pathway. Cell Death Dis. 2019;10:630. doi: 10.1038/s41419-019-1733-8.", "ArticleIdList": ["10.1038/s41419-019-1733-8", "PMC6702205", "31431619"]}, {"Citation": "Qian Y., Liu Z., Yan H., Yuan Y., Levenson A.S., Li K. Pterostilbene Inhibits MTA1/HDAC1 Complex Leading to PTEN Acetylation in Hepatocellular Carcinoma. Biomed. Pharmacother. 2018;101:852\u2013859. doi: 10.1016/j.biopha.2018.03.022.", "ArticleIdList": ["10.1016/j.biopha.2018.03.022", "29635894"]}, {"Citation": "Anand David A., Arulmoli R., Parasuraman S. Overviews of Biological Importance of Quercetin: A Bioactive Flavonoid. Pharmacogn. Rev. 2016;10:84. doi: 10.4103/0973-7847.194044.", "ArticleIdList": ["10.4103/0973-7847.194044", "PMC5214562", "28082789"]}, {"Citation": "Wu H., Pan L., Gao C., Xu H., Li Y., Zhang L., Ma L., Meng L., Sun X., Qin H. Quercetin Inhibits the Proliferation of Glycolysis-Addicted HCC Cells by Reducing Hexokinase 2 and Akt-MTOR Pathway. Molecules. 2019;24:1993. doi: 10.3390/molecules24101993.", "ArticleIdList": ["10.3390/molecules24101993", "PMC6572074", "31137633"]}, {"Citation": "Zhao P., Mao J.-M., Zhang S.-Y., Zhou Z.-Q., Tan Y., Zhang Y. Quercetin Induces HepG2 Cell Apoptosis by Inhibiting Fatty Acid Biosynthesis. Oncol. Lett. 2014;8:765\u2013769. doi: 10.3892/ol.2014.2159.", "ArticleIdList": ["10.3892/ol.2014.2159", "PMC4081423", "25009654"]}, {"Citation": "Malhotra A., Bath S., Elbarbry F. An Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of Resveratrol. Oxid. Med. Cell. Longev. 2015;2015:803971. doi: 10.1155/2015/803971.", "ArticleIdList": ["10.1155/2015/803971", "PMC4477248", "26180596"]}, {"Citation": "Ismail N., Abdel\u2013Mottaleb Y., Eissa Ahmed A.A., El-Maraghy N.N. Novel Combination of Thymoquinone and Resveratrol Enhances Anticancer Effect on Hepatocellular Carcinoma Cell Line. Future J. Pharm. Sci. 2018;4:41\u201346. doi: 10.1016/j.fjps.2017.08.001.", "ArticleIdList": ["10.1016/j.fjps.2017.08.001"]}, {"Citation": "Karakurt S. Modulatory Effects of Rutin on the Expression of Cytochrome P450s and Antioxidant Enzymes in Human Hepatoma Cells. Acta Pharm. 2016;66:491\u2013502. doi: 10.1515/acph-2016-0046.", "ArticleIdList": ["10.1515/acph-2016-0046", "27749250"]}, {"Citation": "Peng W., Hu C., Shu Z., Han T., Qin L., Zheng C. Antitumor Activity of Tatariside F Isolated from Roots of Fagopyrum Tataricum (L.) Gaertn against H22 Hepatocellular Carcinoma via up-Regulation of P53. Phytomedicine. 2015;22:730\u2013736. doi: 10.1016/j.phymed.2015.05.003.", "ArticleIdList": ["10.1016/j.phymed.2015.05.003", "26141759"]}, {"Citation": "Jehan S., Zhong C., Li G., Bakhtiar S.Z., Li D., Sui G. Thymoquinone Selectively Induces Hepatocellular Carcinoma Cell Apoptosis in Synergism with Clinical Therapeutics and Dependence of P53 Status. Front. Pharmacol. 2020;11:555283. doi: 10.3389/fphar.2020.555283.", "ArticleIdList": ["10.3389/fphar.2020.555283", "PMC7522566", "33041795"]}, {"Citation": "Kim G.-H., Kan S.-Y., Kang H., Lee S., Ko H.M., Kim J.H., Lim J.-H. Ursolic Acid Suppresses Cholesterol Biosynthesis and Exerts Anti-Cancer Effects in Hepatocellular Carcinoma Cells. Int. J. Mol. Sci. 2019;20:4767. doi: 10.3390/ijms20194767.", "ArticleIdList": ["10.3390/ijms20194767", "PMC6802365", "31561416"]}, {"Citation": "Liao W., Fan L., Zheng Z., Liu H., Deng H., Li M., Liu F., Yang A. Ziyuglycoside II Exerts Antiproliferative and Antimetastasis Effects on Hepatocellular Carcinoma Cells. Anticancer Drugs. 2020;31:819\u2013827. doi: 10.1097/CAD.0000000000000918.", "ArticleIdList": ["10.1097/CAD.0000000000000918", "32097137"]}, {"Citation": "Patra S., Pradhan B., Nayak R., Behera C., Panda K.C., Das S., Jena M., Bhutia S.K. Apoptosis and Autophagy Modulating Dietary Phytochemicals in Cancer Therapeutics: Current Evidences and Future Perspectives. Phyther. Res. 2021;35:4194\u20134214. doi: 10.1002/ptr.7082.", "ArticleIdList": ["10.1002/ptr.7082", "33749909"]}, {"Citation": "Granado-Serrano A.B., Mart\u00edn M.A., Bravo L., Goya L., Ramos S. Quercetin Induces Apoptosis via Caspase Activation, Regulation of Bcl-2, and Inhibition of PI-3-Kinase/Akt and ERK Pathways in a Human Hepatoma Cell Line (HepG2) J. Nutr. 2006;136:2715\u20132721. doi: 10.1093/jn/136.11.2715.", "ArticleIdList": ["10.1093/jn/136.11.2715", "17056790"]}, {"Citation": "Nishikawa T., Nakajima T., Moriguchi M., Jo M., Sekoguchi S., Ishii M., Takashima H., Katagishi T., Kimura H., Minami M., et al. A Green Tea Polyphenol, Epigalocatechin-3-Gallate, Induces Apoptosis of Human Hepatocellular Carcinoma, Possibly through Inhibition of Bcl-2 Family Proteins. J. Hepatol. 2006;44:1074\u20131082. doi: 10.1016/j.jhep.2005.11.045.", "ArticleIdList": ["10.1016/j.jhep.2005.11.045", "16481065"]}, {"Citation": "Chauhan A., Islam A.U., Prakash H., Singh S. Phytochemicals Targeting NF-\u039aB Signaling: Potential Anti-Cancer Interventions. J. Pharm. Anal. 2022;12:394\u2013405. doi: 10.1016/j.jpha.2021.07.002.", "ArticleIdList": ["10.1016/j.jpha.2021.07.002", "PMC9257438", "35811622"]}, {"Citation": "Wu J.-M., Sheng H., Saxena R., Skill N.J., Bhat-Nakshatri P., Yu M., Nakshatri H., Maluccio M.A. NF-\u039aB Inhibition in Human Hepatocellular Carcinoma and Its Potential as Adjunct to Sorafenib Based Therapy. Cancer Lett. 2009;278:145\u2013155. doi: 10.1016/j.canlet.2008.12.031.", "ArticleIdList": ["10.1016/j.canlet.2008.12.031", "19303700"]}, {"Citation": "Kavitha K., Priyadarsini R.V., Anitha P., Ramalingam K., Sakthivel R., Purushothaman G., Singh A.K., Karunagaran D., Nagini S. Nimbolide, a Neem Limonoid Abrogates Canonical NF-\u039aB and Wnt Signaling to Induce Caspase-Dependent Apoptosis in Human Hepatocarcinoma (HepG2) Cells. Eur. J. Pharmacol. 2012;681:6\u201314. doi: 10.1016/j.ejphar.2012.01.024.", "ArticleIdList": ["10.1016/j.ejphar.2012.01.024", "22327045"]}, {"Citation": "Shu G., Yue L., Zhao W., Xu C., Yang J., Wang S., Yang X. Isoliensinine, a Bioactive Alkaloid Derived from Embryos of Nelumbo Nucifera, Induces Hepatocellular Carcinoma Cell Apoptosis through Suppression of NF-\u039aB Signaling. J. Agric. Food Chem. 2015;63:8793\u20138803. doi: 10.1021/acs.jafc.5b02993.", "ArticleIdList": ["10.1021/acs.jafc.5b02993", "26389520"]}, {"Citation": "Chuang T.-Y., Wu H.-L., Min J., Diamond M., Azziz R., Chen Y.-H. Berberine Regulates the Protein Expression of Multiple Tumorigenesis-Related Genes in Hepatocellular Carcinoma Cell Lines. Cancer Cell Int. 2017;17:59. doi: 10.1186/s12935-017-0429-3.", "ArticleIdList": ["10.1186/s12935-017-0429-3", "PMC5450260", "28572744"]}, {"Citation": "Lee W.J., Shim J.-Y., Zhu B.T. Mechanisms for the Inhibition of DNA Methyltransferases by Tea Catechins and Bioflavonoids. Mol. Pharmacol. 2005;68:1018\u20131030. doi: 10.1124/mol.104.008367.", "ArticleIdList": ["10.1124/mol.104.008367", "16037419"]}, {"Citation": "Liu A., Wu Q., Peng D., Ares I., Anad\u00f3n A., Lopez-Torres B., Mart\u00ednez-Larra\u00f1aga M., Wang X., Mart\u00ednez M. A Novel Strategy for the Diagnosis, Prognosis, Treatment, and Chemoresistance of Hepatocellular Carcinoma: DNA Methylation. Med. Res. Rev. 2020;40:1973\u20132018. doi: 10.1002/med.21696.", "ArticleIdList": ["10.1002/med.21696", "32525219"]}, {"Citation": "Bhatia N., Zhao J., Wolf D.M., Agarwal R. Inhibition of Human Carcinoma Cell Growth and DNA Synthesis by Silibinin, an Active Constituent of Milk Thistle: Comparison with Silymarin. Cancer Lett. 1999;147:77\u201384. doi: 10.1016/S0304-3835(99)00276-1.", "ArticleIdList": ["10.1016/S0304-3835(99)00276-1", "10660092"]}, {"Citation": "Hsieh T., Halicka D., Lu X., Kunicki J., Guo J., Darzynkiewicz Z., Wu J.M. Effects of Resveratrol on the G0\u2013G1 Transition and Cell Cycle Progression of Mitogenically Stimulated Human Lymphocytes. Biochem. Biophys. Res. Commun. 2002;297:1311\u20131317. doi: 10.1016/S0006-291X(02)02384-7.", "ArticleIdList": ["10.1016/S0006-291X(02)02384-7", "12372431"]}, {"Citation": "Tyagi A., Agarwal R., Agarwal C. Grape Seed Extract Inhibits EGF-Induced and Constitutively Active Mitogenic Signaling but Activates JNK in Human Prostate Carcinoma DU145 Cells: Possible Role in Antiproliferation and Apoptosis. Oncogene. 2003;22:1302\u20131316. doi: 10.1038/sj.onc.1206265.", "ArticleIdList": ["10.1038/sj.onc.1206265", "12618755"]}, {"Citation": "Rodriguez S., Skeet K., Mehmetoglu-Gurbuz T., Goldfarb M., Karri S., Rocha J., Shahinian M., Yazadi A., Poudel S., Subramani R. Phytochemicals as an Alternative or Integrative Option, in Conjunction with Conventional Treatments for Hepatocellular Carcinoma. Cancers. 2021;13:5753. doi: 10.3390/cancers13225753.", "ArticleIdList": ["10.3390/cancers13225753", "PMC8616323", "34830907"]}, {"Citation": "Slika H., Mansour H., Wehbe N., Nasser S.A., Iratni R., Nasrallah G., Shaito A., Ghaddar T., Kobeissy F., Eid A.H. Therapeutic Potential of Flavonoids in Cancer: ROS-Mediated Mechanisms. Biomed. Pharmacother. 2022;146:112442. doi: 10.1016/j.biopha.2021.112442.", "ArticleIdList": ["10.1016/j.biopha.2021.112442", "35062053"]}, {"Citation": "Folkman J. Fundamental Concepts of the Angiogenic Process. Curr. Mol. Med. 2003;3:643\u2013651. doi: 10.2174/1566524033479465.", "ArticleIdList": ["10.2174/1566524033479465", "14601638"]}, {"Citation": "Varghese E., Liskova A., Kubatka P., Samuel S.M., B\u00fcsselberg D. Anti-Angiogenic Effects of Phytochemicals on MiRNA Regulating Breast Cancer Progression. Biomolecules. 2020;10:191. doi: 10.3390/biom10020191.", "ArticleIdList": ["10.3390/biom10020191", "PMC7072640", "32012744"]}, {"Citation": "Mendell J.T., Olson E.N. MicroRNAs in Stress Signaling and Human Disease. Cell. 2012;148:1172\u20131187. doi: 10.1016/j.cell.2012.02.005.", "ArticleIdList": ["10.1016/j.cell.2012.02.005", "PMC3308137", "22424228"]}, {"Citation": "Lah J.J. Effects and Mechanisms of Silibinin on Human Hepatoma Cell Lines. World J. Gastroenterol. 2007;13:5299. doi: 10.3748/wjg.v13.i40.5299.", "ArticleIdList": ["10.3748/wjg.v13.i40.5299", "PMC4171317", "17879397"]}, {"Citation": "Pan Z., Zhuang J., Ji C., Cai Z., Liao W., Huang Z. Curcumin Inhibits Hepatocellular Carcinoma Growth by Targeting VEGF Expression. Oncol. Lett. 2018;15:4821\u20134826. doi: 10.3892/ol.2018.7988.", "ArticleIdList": ["10.3892/ol.2018.7988", "PMC5840714", "29552121"]}, {"Citation": "Sur S., Pal D., Roy R., Barua A., Roy A., Saha P., Panda C.K. Tea Polyphenols EGCG and TF Restrict Tongue and Liver Carcinogenesis Simultaneously Induced by N-Nitrosodiethylamine in Mice. Toxicol. Appl. Pharmacol. 2016;300:34\u201346. doi: 10.1016/j.taap.2016.03.016.", "ArticleIdList": ["10.1016/j.taap.2016.03.016", "27058323"]}, {"Citation": "Li C., Cai G., Song D., Gao R., Teng P., Zhou L., Ji Q., Sui H., Cai J., Li Q., et al. Development of EGFR-Targeted Evodiamine Nanoparticles for the Treatment of Colorectal Cancer. Biomater. Sci. 2019;7:3627\u20133639. doi: 10.1039/C9BM00613C.", "ArticleIdList": ["10.1039/C9BM00613C", "31328737"]}, {"Citation": "Tong D., Qu H., Meng X., Jiang Y., Liu D., Ye S., Chen H., Jin Y., Fu S., Geng J. S-Allylmercaptocysteine Promotes MAPK Inhibitor-Induced Apoptosis by Activating the TGF-\u03b2 Signaling Pathway in Cancer Cells. Oncol. Rep. 2014;32:1124\u20131132. doi: 10.3892/or.2014.3295.", "ArticleIdList": ["10.3892/or.2014.3295", "24970681"]}, {"Citation": "Furtado N.J.C., Pirson L., Edelberg H., Miranda L.M., Loira-Pastoriza C., Preat V., Larondelle Y., Andr\u00e9 C. Pentacyclic Triterpene Bioavailability: An Overview of In Vitro and In Vivo Studies. Molecules. 2017;22:400. doi: 10.3390/molecules22030400.", "ArticleIdList": ["10.3390/molecules22030400", "PMC6155290", "28273859"]}, {"Citation": "Tan O.J., Loo H.L., Thiagarajah G., Palanisamy U.D., Sundralingam U. Improving Oral Bioavailability of Medicinal Herbal Compounds through Lipid-Based Formulations\u2014A Scoping Review. Phytomedicine. 2021;90:153651. doi: 10.1016/j.phymed.2021.153651.", "ArticleIdList": ["10.1016/j.phymed.2021.153651", "34340903"]}, {"Citation": "Gonz\u00e1lez-Ruiz V., Cores \u00c1., Mart\u00edn-C\u00e1mara O., Orellana K., Cervera-Carrasc\u00f3n V., Michalska P., Olives A.I., Le\u00f3n R., Mart\u00edn M.A., Men\u00e9ndez J.C. Enhanced Stability and Bioactivity of Natural Anticancer Topoisomerase I Inhibitors through Cyclodextrin Complexation. Pharmaceutics. 2021;13:1609. doi: 10.3390/pharmaceutics13101609.", "ArticleIdList": ["10.3390/pharmaceutics13101609", "PMC8537677", "34683902"]}, {"Citation": "Mirhadi E., Rezaee M., Malaekeh-Nikouei B. Nano Strategies for Berberine Delivery, a Natural Alkaloid of Berberis. Biomed. Pharmacother. 2018;104:465\u2013473. doi: 10.1016/j.biopha.2018.05.067.", "ArticleIdList": ["10.1016/j.biopha.2018.05.067", "29793179"]}, {"Citation": "Tao Y., Wang J., Xu X. Emerging and Innovative Theranostic Approaches for Mesoporous Silica Nanoparticles in Hepatocellular Carcinoma: Current Status and Advances. Front. Bioeng. Biotechnol. 2020;8:184. doi: 10.3389/fbioe.2020.00184.", "ArticleIdList": ["10.3389/fbioe.2020.00184", "PMC7075945", "32211399"]}, {"Citation": "Kashkooli F.M., Soltani M., Souri M. Controlled Anti-Cancer Drug Release through Advanced Nano-Drug Delivery Systems: Static and Dynamic Targeting Strategies. J. Control. Release. 2020;327:316\u2013349. doi: 10.1016/j.jconrel.2020.08.012.", "ArticleIdList": ["10.1016/j.jconrel.2020.08.012", "32800878"]}, {"Citation": "Bilal M., Qindeel M., Raza A., Mehmood S., Rahdar A. Stimuli-Responsive Nanoliposomes as Prospective Nanocarriers for Targeted Drug Delivery. J. Drug Deliv. Sci. Technol. 2021;66:102916. doi: 10.1016/j.jddst.2021.102916.", "ArticleIdList": ["10.1016/j.jddst.2021.102916"]}, {"Citation": "Yao J., Feng J., Chen J. External-Stimuli Responsive Systems for Cancer Theranostic. Asian J. Pharm. Sci. 2016;11:585\u2013595. doi: 10.1016/j.ajps.2016.06.001.", "ArticleIdList": ["10.1016/j.ajps.2016.06.001"]}, {"Citation": "Fang Z., Pan S., Gao P., Sheng H., Li L., Shi L., Zhang Y., Cai X. Stimuli-Responsive Charge-Reversal Nano Drug Delivery System: The Promising Targeted Carriers for Tumor Therapy. Int. J. Pharm. 2020;575:118841. doi: 10.1016/j.ijpharm.2019.118841.", "ArticleIdList": ["10.1016/j.ijpharm.2019.118841", "31812795"]}, {"Citation": "Mitchell M.J., Billingsley M.M., Haley R.M., Wechsler M.E., Peppas N.A., Langer R. Engineering Precision Nanoparticles for Drug Delivery. Nat. Rev. Drug Discov. 2021;20:101\u2013124. doi: 10.1038/s41573-020-0090-8.", "ArticleIdList": ["10.1038/s41573-020-0090-8", "PMC7717100", "33277608"]}, {"Citation": "Chen M., Li R., Lu X., Dai Y., Chen T., Xing Y., Xue L., Duan Z., Zhou W., Li J. Fabrication and Characterization of L-Ascorbyl Palmitate and Phospholipid-Based Hybrid Liposomes and Their Impacts on the Stability of Loaded Hydrophobic Polyphenols. Food Chem. 2023;398:133953. doi: 10.1016/j.foodchem.2022.133953.", "ArticleIdList": ["10.1016/j.foodchem.2022.133953", "35998486"]}, {"Citation": "Dom\u00ednguez-Arca V., Sab\u00edn J., Garc\u00eda-R\u00edo L., Bastos M., Taboada P., Barbosa S., Prieto G. On the Structure and Stability of Novel Cationic DPPC Liposomes Doped with Gemini Surfactants. J. Mol. Liq. 2022;366:120230. doi: 10.1016/j.molliq.2022.120230.", "ArticleIdList": ["10.1016/j.molliq.2022.120230"]}, {"Citation": "Jagwani S., Jalalpure S., Dhamecha D., Jadhav K., Bohara R. Pharmacokinetic and Pharmacodynamic Evaluation of Resveratrol Loaded Cationic Liposomes for Targeting Hepatocellular Carcinoma. ACS Biomater. Sci. Eng. 2020;6:4969\u20134984. doi: 10.1021/acsbiomaterials.0c00429.", "ArticleIdList": ["10.1021/acsbiomaterials.0c00429", "33455290"]}, {"Citation": "Yue Y., Yang Y., Shi L., Wang Z. Basic Research Suppression of Human Hepatocellular Cancer Cell Proliferation by Brucea Javanica Oil-Loaded Liposomes via Induction of Apoptosis. Arch. Med. Sci. 2015;4:856\u2013862. doi: 10.5114/aoms.2015.53306.", "ArticleIdList": ["10.5114/aoms.2015.53306", "PMC4548038", "26322098"]}, {"Citation": "Li Y., Wu J., Lu Q., Liu X., Wen J., Qi X., Liu J., Lian B., Zhang B., Sun H., et al. GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular Carcinoma. Int. J. Nanomed. 2022;17:2559\u20132575. doi: 10.2147/IJN.S366180.", "ArticleIdList": ["10.2147/IJN.S366180", "PMC9188407", "35698562"]}, {"Citation": "Singh M., Devi S., Rana V.S., Mishra B.B., Kumar J., Ahluwalia V. Delivery of Phytochemicals by Liposome Cargos: Recent Progress, Challenges and Opportunities. J. Microencapsul. 2019;36:215\u2013235. doi: 10.1080/02652048.2019.1617361.", "ArticleIdList": ["10.1080/02652048.2019.1617361", "31092084"]}, {"Citation": "Shu Q., Wu J., Chen Q. Synthesis, Characterization of Liposomes Modified with Biosurfactant MEL-A Loading Betulinic Acid and Its Anticancer Effect in HepG2 Cell. Molecules. 2019;24:3939. doi: 10.3390/molecules24213939.", "ArticleIdList": ["10.3390/molecules24213939", "PMC6864557", "31683639"]}, {"Citation": "Batool S., Asad M.J., Arshad M., Ahmed W., Sohail M.F., Abbasi S.W., Ahmad S., Saleem R.S.Z., Ahmed M.S. In Silico Validation, Fabrication and Evaluation of Nano-Liposomes of Bistorta Amplexicaulis Extract for Improved Anticancer Activity Against Hepatoma Cell Line (HepG2) Curr. Drug Deliv. 2021;18:922\u2013934. doi: 10.2174/1567201818666210316113640.", "ArticleIdList": ["10.2174/1567201818666210316113640", "33726649"]}, {"Citation": "Chen X., Hu X., Hu J., Qiu Z., Yuan M., Zheng G. Celastrol-Loaded Galactosylated Liposomes Effectively Inhibit AKT/c-Met-Triggered Rapid Hepatocarcinogenesis in Mice. Mol. Pharm. 2020;17:738\u2013747. doi: 10.1021/acs.molpharmaceut.9b00428.", "ArticleIdList": ["10.1021/acs.molpharmaceut.9b00428", "31904241"]}, {"Citation": "Wang Y., Ding R., Zhang Z., Zhong C., Wang J., Wang M. Curcumin-Loaded Liposomes with the Hepatic and Lysosomal Dual-Targeted Effects for Therapy of Hepatocellular Carcinoma. Int. J. Pharm. 2021;602:120628. doi: 10.1016/j.ijpharm.2021.120628.", "ArticleIdList": ["10.1016/j.ijpharm.2021.120628", "33892061"]}, {"Citation": "Cheng Y., Zhao P., Wu S., Yang T., Chen Y., Zhang X., He C., Zheng C., Li K., Ma X., et al. Cisplatin and Curcumin Co-Loaded Nano-Liposomes for the Treatment of Hepatocellular Carcinoma. Int. J. Pharm. 2018;545:261\u2013273. doi: 10.1016/j.ijpharm.2018.05.007.", "ArticleIdList": ["10.1016/j.ijpharm.2018.05.007", "29730175"]}, {"Citation": "Liu C., Zhou Z., Chen Y., Liu J., Wang Y., Liu H. Targeted Delivery of Garcinia Glycosides by Reconstituted High-Density Lipoprotein Nano-Complexes. J. Microencapsul. 2018;35:115\u2013120. doi: 10.1080/02652048.2017.1413146.", "ArticleIdList": ["10.1080/02652048.2017.1413146", "29195484"]}, {"Citation": "Yang J., Pei H., Luo H., Fu A., Yang H., Hu J., Zhao C., Chai L., Chen X., Shao X., et al. Non-Toxic Dose of Liposomal Honokiol Suppresses Metastasis of Hepatocellular Carcinoma through Destabilizing EGFR and Inhibiting the Downstream Pathways. Oncotarget. 2017;8:915\u2013932. doi: 10.18632/oncotarget.13687.", "ArticleIdList": ["10.18632/oncotarget.13687", "PMC5352206", "27906672"]}, {"Citation": "Li D., Liu S., Zhu J., Shen L., Zhang Q.Y., Zhu H. Folic Acid Modified TPGS as a Novel Nano-Micelle for Delivery of Nitidine Chloride to Improve Apoptosis Induction in Huh7 Human Hepatocellular Carcinoma. BMC Pharmacol. Toxicol. 2021;22:1. doi: 10.1186/s40360-020-00461-y.", "ArticleIdList": ["10.1186/s40360-020-00461-y", "PMC7789002", "33407916"]}, {"Citation": "Zhong Z., Liu Z., Zhang X., Huang J., Yu X., Li J., Xiong D., Sun X., Luo Y. Effect of a Controlled-Release Drug Delivery System Made of Oleanolic Acid Formulated into Multivesicular Liposomes on Hepatocellular Carcinoma in Vitro and in Vivo. Int. J. Nanomed. 2016;11:3111\u20133129. doi: 10.2147/IJN.S108445.", "ArticleIdList": ["10.2147/IJN.S108445", "PMC4948731", "27471381"]}, {"Citation": "Ochi M.M., Amoabediny G., Rezayat S.M., Akbarzadeh A., Ebrahimi B. In Vitro Co-Delivery Evaluation of Novel Pegylated Nano-Liposomal Herbal Drugs of Silibinin and Glycyrrhizic Acid (Nano-Phytosome) to Hepatocellular Carcinoma Cells. Cell J. 2016;18:135\u2013148. doi: 10.22074/cellj.2016.4308.", "ArticleIdList": ["10.22074/cellj.2016.4308", "PMC4988412", "27540518"]}, {"Citation": "Hu X., Zhang J., Deng L., Hu H., Hu J., Zheng G. Galactose-Modified PH-Sensitive Niosomes for Controlled Release and Hepatocellular Carcinoma Target Delivery of Tanshinone IIA. AAPS PharmSciTech. 2021;22:96. doi: 10.1208/s12249-021-01973-4.", "ArticleIdList": ["10.1208/s12249-021-01973-4", "PMC7946689", "33694067"]}, {"Citation": "Zhang L., Zhang S., Jiang M., Lu L., Ding Y., Ma N., Zhao Y., Xuchen S., Zhang N. Novel Timosaponin AIII-Based Multifunctional Liposomal Delivery System for Synergistic Therapy Against Hepatocellular Carcinoma Cancer. Int. J. Nanomed. 2021;16:5531\u20135550. doi: 10.2147/IJN.S313759.", "ArticleIdList": ["10.2147/IJN.S313759", "PMC8379713", "34429598"]}, {"Citation": "Zheng Y., Kong F., Liu S., Liu X., Pei D., Miao X. Membrane Protein-Chimeric Liposome-Mediated Delivery of Triptolide for Targeted Hepatocellular Carcinoma Therapy. Drug Deliv. 2021;28:2033\u20132043. doi: 10.1080/10717544.2021.1983072.", "ArticleIdList": ["10.1080/10717544.2021.1983072", "PMC8477919", "34569906"]}, {"Citation": "Yu L., Wang Z., Mo Z., Zou B., Yang Y., Sun R., Ma W., Yu M., Zhang S., Yu Z. Synergetic Delivery of Triptolide and Ce6 with Light-Activatable Liposomes for Efficient Hepatocellular Carcinoma Therapy. Acta Pharm. Sin. B. 2021;11:2004\u20132015. doi: 10.1016/j.apsb.2021.02.001.", "ArticleIdList": ["10.1016/j.apsb.2021.02.001", "PMC8343191", "34386334"]}, {"Citation": "Li Z., Yang G., Han L., Wang R., Gong C., Yuan Y. Sorafenib and Triptolide Loaded Cancer Cell-Platelet Hybrid Membrane-Camouflaged Liquid Crystalline Lipid Nanoparticles for the Treatment of Hepatocellular Carcinoma. J. Nanobiotechnol. 2021;19:360. doi: 10.1186/s12951-021-01095-w.", "ArticleIdList": ["10.1186/s12951-021-01095-w", "PMC8576878", "34749742"]}, {"Citation": "Wang B., Xu Q., Zhou C., Lin Y. Liposomes Co-Loaded with Ursolic Acid and Ginsenoside Rg3 in the Treatment of Hepatocellular Carcinoma. Acta Biochim. Pol. 2021;68:711\u2013715. doi: 10.18388/abp.2020_5608.", "ArticleIdList": ["10.18388/abp.2020_5608", "34730903"]}, {"Citation": "Nisha R., Kumar P., Gautam A.K., Bera H., Bhattacharya B., Parashar P., Saraf S.A., Saha S. Assessments of in Vitro and in Vivo Antineoplastic Potentials of \u03b2-Sitosterol-Loaded PEGylated Niosomes against Hepatocellular Carcinoma. J. Liposome Res. 2021;31:304\u2013315. doi: 10.1080/08982104.2020.1820520.", "ArticleIdList": ["10.1080/08982104.2020.1820520", "32901571"]}, {"Citation": "Guo S.-J., Ma C.-G., Hu Y.-Y., Bai G., Song Z.-J., Cao X.-Q. Solid Lipid Nanoparticles for Phytosterols Delivery: The Acyl Chain Number of the Glyceride Matrix Affects the Arrangement, Stability, and Release. Food Chem. 2022;394:133412. doi: 10.1016/j.foodchem.2022.133412.", "ArticleIdList": ["10.1016/j.foodchem.2022.133412", "35728468"]}, {"Citation": "Sun S., Shang E., Ju A., Li Y., Wu Q., Li Q., Yang Y., Guo Y., Yang D., Lv S. Tumor-Targeted Hyaluronic Acid-MPEG Modified Nanostructured Lipid Carriers for Cantharidin Delivery: An in Vivo and in Vitro Study. Fitoterapia. 2021;155:105033. doi: 10.1016/j.fitote.2021.105033.", "ArticleIdList": ["10.1016/j.fitote.2021.105033", "34517057"]}, {"Citation": "Kunjiappan S., Sankaranarayanan M., Karan Kumar B., Pavadai P., Babkiewicz E., Maszczyk P., Glodkowska-Mrowka E., Arunachalam S., Ram Kumar Pandian S., Ravishankar V., et al. Capsaicin-Loaded Solid Lipid Nanoparticles: Design, Biodistribution, in Silico Modeling and in Vitro Cytotoxicity Evaluation. Nanotechnology. 2021;32:095101. doi: 10.1088/1361-6528/abc57e.", "ArticleIdList": ["10.1088/1361-6528/abc57e", "33113518"]}, {"Citation": "Zhao X., Chen Q., Li Y., Tang H., Liu W., Yang X. Doxorubicin and Curcumin Co-Delivery by Lipid Nanoparticles for Enhanced Treatment of Diethylnitrosamine-Induced Hepatocellular Carcinoma in Mice. Eur. J. Pharm. Biopharm. 2015;93:27\u201336. doi: 10.1016/j.ejpb.2015.03.003.", "ArticleIdList": ["10.1016/j.ejpb.2015.03.003", "25770771"]}, {"Citation": "Rahman M., Al-Ghamdi S.A., Alharbi K.S., Beg S., Sharma K., Anwar F., Al-Abbasi F.A., Kumar V. Ganoderic Acid Loaded Nano-Lipidic Carriers Improvise Treatment of Hepatocellular Carcinoma. Drug Deliv. 2019;26:782\u2013793. doi: 10.1080/10717544.2019.1606865.", "ArticleIdList": ["10.1080/10717544.2019.1606865", "PMC6711158", "31357897"]}, {"Citation": "Zhu J., Huang Y., Zhang J., Feng Y., Shen L. Formulation, Preparation and Evaluation of Nanostructured Lipid Carrier Containing Naringin and Coix Seed Oil for Anti-Tumor Application Based on \u201cUnification of Medicines and Excipients\u201d. Drug Des. Dev. Ther. 2020;14:1481\u20131491. doi: 10.2147/DDDT.S236997.", "ArticleIdList": ["10.2147/DDDT.S236997", "PMC7171570", "32368009"]}, {"Citation": "Varshosaz J., Jafarian A., Salehi G., Zolfaghari B. Comparing Different Sterol Containing Solid Lipid Nanoparticles for Targeted Delivery of Quercetin in Hepatocellular Carcinoma. J. Liposome Res. 2014;24:191\u2013203. doi: 10.3109/08982104.2013.868476.", "ArticleIdList": ["10.3109/08982104.2013.868476", "24354715"]}, {"Citation": "Rahman M., Almalki W.H., Afzal O., Altamimi A.S.A., Kazmi I., Al-Abbasi F.A., Choudhry H., Alenezi S., Barkat M.A., Beg S., et al. Cationic Solid Lipid Nanoparticles of Resveratrol for Hepatocellular Carcinoma Treatment: Systematic Optimization, in Vitro Characterization and Preclinical Investigation. Int. J. Nanomed. 2020;15:9283\u20139299. doi: 10.2147/IJN.S277545.", "ArticleIdList": ["10.2147/IJN.S277545", "PMC7695602", "33262588"]}, {"Citation": "Lagoa R., Silva J., Rodrigues J.R., Bishayee A. Advances in Phytochemical Delivery Systems for Improved Anticancer Activity. Biotechnol. Adv. 2020;38:107382. doi: 10.1016/j.biotechadv.2019.04.004.", "ArticleIdList": ["10.1016/j.biotechadv.2019.04.004", "30978386"]}, {"Citation": "Bhattacharya S., Mondal L., Mukherjee B., Dutta L., Ehsan I., Debnath M.C., Gaonkar R.H., Pal M.M., Majumdar S. Apigenin Loaded Nanoparticle Delayed Development of Hepatocellular Carcinoma in Rats. Nanomed. Nanotechnol. Biol. Med. 2018;14:1905\u20131917. doi: 10.1016/j.nano.2018.05.011.", "ArticleIdList": ["10.1016/j.nano.2018.05.011", "29802937"]}, {"Citation": "Tian H., Huang Y., He J., Zhang M., Ni P. CD147 Monoclonal Antibody Targeted Reduction-Responsive Camptothecin Polyphosphoester Nanomedicine for Drug Delivery in Hepatocellular Carcinoma Cells. ACS Appl. Bio Mater. 2021;4:4422\u20134431. doi: 10.1021/acsabm.1c00177.", "ArticleIdList": ["10.1021/acsabm.1c00177", "35006854"]}, {"Citation": "Sarika P.R., James N.R., Kumar P.R.A., Raj D.K., Kumary T.V. Gum Arabic-Curcumin Conjugate Micelles with Enhanced Loading for Curcumin Delivery to Hepatocarcinoma Cells. Carbohydr. Polym. 2015;134:167\u2013174. doi: 10.1016/j.carbpol.2015.07.068.", "ArticleIdList": ["10.1016/j.carbpol.2015.07.068", "26428113"]}, {"Citation": "Mondal J., Khuda-Bukhsh A.R. Cisplatin and Farnesol Co-Encapsulated PLGA Nano-Particles Demonstrate Enhanced Anti-Cancer Potential against Hepatocellular Carcinoma Cells in Vitro. Mol. Biol. Rep. 2020;47:3615\u20133628. doi: 10.1007/s11033-020-05455-x.", "ArticleIdList": ["10.1007/s11033-020-05455-x", "32314187"]}, {"Citation": "Abd-Rabou A.A., Ahmed H.H. CS-PEG Decorated PLGA Nano-Prototype for Delivery of Bioactive Compounds: A Novel Approach for Induction of Apoptosis in HepG2 Cell Line. Adv. Med. Sci. 2017;62:357\u2013367. doi: 10.1016/j.advms.2017.01.003.", "ArticleIdList": ["10.1016/j.advms.2017.01.003", "28521254"]}, {"Citation": "Kumar V., Bhatt P., Rahman M., Kaithwas G., Choudhry H., Al-Abbasi F., Anwar F., Verma A. Fabrication, Optimization, and Characterization of Umbelliferone \u03b2-D-Galactopyranoside-Loaded PLGA Nanoparticles in Treatment of Hepatocellular Carcinoma: In Vitro and in Vivo Studies. Int. J. Nanomed. 2017;12:6747\u20136758. doi: 10.2147/IJN.S136629.", "ArticleIdList": ["10.2147/IJN.S136629", "PMC5600267", "28932118"]}, {"Citation": "Zhou M., Yi Y., Liu L., Lin Y., Li J., Ruan J., Zhong Z. Polymeric Micelles Loading with Ursolic Acid Enhancing Anti-Tumor Effect on Hepatocellular Carcinoma. J. Cancer. 2019;10:5820\u20135831. doi: 10.7150/jca.30865.", "ArticleIdList": ["10.7150/jca.30865", "PMC6843872", "31737119"]}, {"Citation": "Rao P.V., Nallappan D., Madhavi K., Rahman S., Jun Wei L., Gan S.H. Phytochemicals and Biogenic Metallic Nanoparticles as Anticancer Agents. Oxid. Med. Cell. Longev. 2016;2016:1\u201315. doi: 10.1155/2016/3685671.", "ArticleIdList": ["10.1155/2016/3685671", "PMC4781993", "27057273"]}, {"Citation": "Krishnan G., Subramaniyan J., Chengalvarayan Subramani P., Muralidharan B., Thiruvengadam D. Hesperetin Conjugated PEGylated Gold Nanoparticles Exploring the Potential Role in Anti-Inflammation and Anti-Proliferation during Diethylnitrosamine-Induced Hepatocarcinogenesis in Rats. Asian J. Pharm. Sci. 2017;12:442\u2013455. doi: 10.1016/j.ajps.2017.04.001.", "ArticleIdList": ["10.1016/j.ajps.2017.04.001", "PMC7032104", "32104357"]}, {"Citation": "Zhang D., Zhang J., Zeng J., Li Z., Zuo H., Huang C., Zhao X. Nano-Gold Loaded with Resveratrol Enhance the Anti-Hepatoma Effect of Resveratrol In Vitro and In Vivo. J. Biomed. Nanotechnol. 2019;15:288\u2013300. doi: 10.1166/jbn.2019.2682.", "ArticleIdList": ["10.1166/jbn.2019.2682", "30596551"]}, {"Citation": "Gao W., Fan X., Bi Y., Zhou Z., Yuan Y. Preparation of NIR-Responsive Gold Nanocages as Efficient Carrier for Controlling Release of EGCG in Anticancer Application. Front. Chem. 2022;10:926002. doi: 10.3389/fchem.2022.926002.", "ArticleIdList": ["10.3389/fchem.2022.926002", "PMC9201208", "35720982"]}, {"Citation": "Thi T.T.H., Suys E.J.A., Lee J.S., Nguyen D.H., Park K.D., Truong N.P. Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines. Vaccines. 2021;9:359. doi: 10.3390/vaccines9040359.", "ArticleIdList": ["10.3390/vaccines9040359", "PMC8069344", "33918072"]}, {"Citation": "Bay\u00f3n-Cordero L., Alkorta I., Arana L. Application of Solid Lipid Nanoparticles to Improve the Efficiency of Anticancer Drugs. Nanomaterials. 2019;9:474. doi: 10.3390/nano9030474.", "ArticleIdList": ["10.3390/nano9030474", "PMC6474076", "30909401"]}, {"Citation": "Ruenraroengsak P., Novak P., Berhanu D., Thorley A.J., Valsami-Jones E., Gorelik J., Korchev Y.E., Tetley T.D. Respiratory Epithelial Cytotoxicity and Membrane Damage (Holes) Caused by Amine-Modified Nanoparticles. Nanotoxicology. 2012;6:94\u2013108. doi: 10.3109/17435390.2011.558643.", "ArticleIdList": ["10.3109/17435390.2011.558643", "21352086"]}, {"Citation": "Chandrakala V., Aruna V., Angajala G. Review on Metal Nanoparticles as Nanocarriers: Current Challenges and Perspectives in Drug Delivery Systems. Emergent Mater. 2022;5:1593\u20131615. doi: 10.1007/s42247-021-00335-x.", "ArticleIdList": ["10.1007/s42247-021-00335-x", "PMC8724657", "35005431"]}, {"Citation": "Zhang J., Song J., Wu D., Wang J., Dong W. Hesperetin Induces the Apoptosis of Hepatocellular Carcinoma Cells via Mitochondrial Pathway Mediated by the Increased Intracellular Reactive Oxygen Species, ATP and Calcium. Med. Oncol. 2015;32:101. doi: 10.1007/s12032-015-0516-z.", "ArticleIdList": ["10.1007/s12032-015-0516-z", "25737432"]}, {"Citation": "Dobrzynska M., Napierala M., Florek E. Flavonoid Nanoparticles: A Promising Approach for Cancer Therapy. Biomolecules. 2020;10:1268. doi: 10.3390/biom10091268.", "ArticleIdList": ["10.3390/biom10091268", "PMC7564267", "32887473"]}, {"Citation": "Chen T., Gong T., Zhao T., Fu Y., Zhang Z., Gong T. A Comparison Study between Lycobetaine-Loaded Nanoemulsion and Liposome Using NRGD as Therapeutic Adjuvant for Lung Cancer Therapy. Eur. J. Pharm. Sci. 2018;111:293\u2013302. doi: 10.1016/j.ejps.2017.09.041.", "ArticleIdList": ["10.1016/j.ejps.2017.09.041", "28966099"]}, {"Citation": "Kaur V., Kumar M., Kumar A., Kaur K., Dhillon V.S., Kaur S. Pharmacotherapeutic Potential of Phytochemicals: Implications in Cancer Chemoprevention and Future Perspectives. Biomed. Pharmacother. 2018;97:564\u2013586. doi: 10.1016/j.biopha.2017.10.124.", "ArticleIdList": ["10.1016/j.biopha.2017.10.124", "29101800"]}, {"Citation": "Korga A., Ostrowska M., Jozefczyk A., Iwan M., Wojcik R., Zgorka G., Herbet M., Vilarrubla G.G., Dudka J. Apigenin and Hesperidin Augment the Toxic Effect of Doxorubicin against HepG2 Cells. BMC Pharmacol. Toxicol. 2019;20:22. doi: 10.1186/s40360-019-0301-2.", "ArticleIdList": ["10.1186/s40360-019-0301-2", "PMC6499973", "31053173"]}, {"Citation": "Li J., Duan B., Guo Y., Zhou R., Sun J., Bie B., Yang S., Huang C., Yang J., Li Z. Baicalein Sensitizes Hepatocellular Carcinoma Cells to 5-FU and Epirubicin by Activating Apoptosis and Ameliorating P-Glycoprotein Activity. Biomed. Pharmacother. 2018;98:806\u2013812. doi: 10.1016/j.biopha.2018.01.002.", "ArticleIdList": ["10.1016/j.biopha.2018.01.002", "29571250"]}, {"Citation": "Chang Y.-F., Chi C.-W., Wang J.-J. Reactive Oxygen Species Production Is Involved in Quercetin-Induced Apoptosis in Human Hepatoma Cells. Nutr. Cancer. 2006;55:201\u2013209. doi: 10.1207/s15327914nc5502_12.", "ArticleIdList": ["10.1207/s15327914nc5502_12", "17044776"]}, {"Citation": "Ganta S., Amiji M. Coadministration of Paclitaxel and Curcumin in Nanoemulsion Formulations to Overcome Multidrug Resistance in Tumor Cells. Mol. Pharm. 2009;6:928\u2013939. doi: 10.1021/mp800240j.", "ArticleIdList": ["10.1021/mp800240j", "19278222"]}, {"Citation": "Lu Y., Zhang R., Zhang X., Zhang B., Yao Q. Curcumin May Reverse 5-Fluorouracil Resistance on Colonic Cancer Cells by Regulating TET1-NKD-Wnt Signal Pathway to Inhibit the EMT Progress. Biomed. Pharmacother. 2020;129:110381. doi: 10.1016/j.biopha.2020.110381.", "ArticleIdList": ["10.1016/j.biopha.2020.110381", "32887024"]}, {"Citation": "Duan J., Mansour H.M., Zhang Y., Deng X., Chen Y., Wang J., Pan Y., Zhao J. Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Curcumin in Chitosan/Poly(Butyl Cyanoacrylate) Nanoparticles. Int. J. Pharm. 2012;426:193\u2013201. doi: 10.1016/j.ijpharm.2012.01.020.", "ArticleIdList": ["10.1016/j.ijpharm.2012.01.020", "22274587"]}, {"Citation": "Liu Q., Luo L., Gao X., Zhang D., Feng X., Yang P., Li H., Mao S. Co-Delivery of Daunorubicin and Homoharringtonine in Folic Acid Modified-Liposomes for Enhancing Therapeutic Effect on Acute Myeloid Leukemia. J. Pharm. Sci. 2022;112:123\u2013131. doi: 10.1016/j.xphs.2022.04.014.", "ArticleIdList": ["10.1016/j.xphs.2022.04.014", "35469834"]}, {"Citation": "Liu M., Fu M., Yang X., Jia G., Shi X., Ji J., Liu X., Zhai G. Paclitaxel and Quercetin Co-Loaded Functional Mesoporous Silica Nanoparticles Overcoming Multidrug Resistance in Breast Cancer. Colloids Surf. B Biointerfaces. 2020;196:111284. doi: 10.1016/j.colsurfb.2020.111284.", "ArticleIdList": ["10.1016/j.colsurfb.2020.111284", "32771817"]}, {"Citation": "Singh D., Khan M.A., Akhtar K., Arjmand F., Siddique H.R. Apigenin Alleviates Cancer Drug Sorafenib Induced Multiple Toxic Effects in Swiss Albino Mice via Anti-Oxidative Stress. Toxicol. Appl. Pharmacol. 2022;447:116072. doi: 10.1016/j.taap.2022.116072.", "ArticleIdList": ["10.1016/j.taap.2022.116072", "35613639"]}, {"Citation": "Zhou M., Zhang G., Hu J., Zhu Y., Lan H., Shen X., Lv Y., Huang L. Rutin Attenuates Sorafenib-Induced Chemoresistance and Autophagy in Hepatocellular Carcinoma by Regulating BANCR/MiRNA-590-5P/OLR1 Axis. Int. J. Biol. Sci. 2021;17:3595\u20133607. doi: 10.7150/ijbs.62471.", "ArticleIdList": ["10.7150/ijbs.62471", "PMC8416719", "34512168"]}, {"Citation": "Lin M.-T., Lin C.-L., Lin T.-Y., Cheng C.-W., Yang S.-F., Lin C.-L., Wu C.-C., Hsieh Y.-H., Tsai J.-P. Synergistic Effect of Fisetin Combined with Sorafenib in Human Cervical Cancer HeLa Cells through Activation of Death Receptor-5 Mediated Caspase-8/Caspase-3 and the Mitochondria-Dependent Apoptotic Pathway. Tumor Biol. 2016;37:6987\u20136996. doi: 10.1007/s13277-015-4526-4.", "ArticleIdList": ["10.1007/s13277-015-4526-4", "26662956"]}, {"Citation": "Zhang M., Hagan C.T., Min Y., Foley H., Tian X., Yang F., Mi Y., Au K.M., Medik Y., Roche K., et al. Nanoparticle Co-Delivery of Wortmannin and Cisplatin Synergistically Enhances Chemoradiotherapy and Reverses Platinum Resistance in Ovarian Cancer Models. Biomaterials. 2018;169:1\u201310. doi: 10.1016/j.biomaterials.2018.03.055.", "ArticleIdList": ["10.1016/j.biomaterials.2018.03.055", "PMC5911411", "29631163"]}, {"Citation": "Singh M., Bhatnagar P., Mishra S., Kumar P., Shukla Y., Gupta K.C. PLGA-Encapsulated Tea Polyphenols Enhance the Chemotherapeutic Efficacy of Cisplatin against Human Cancer Cells and Mice Bearing Ehrlich Ascites Carcinoma. Int. J. Nanomed. 2015;10:6789. doi: 10.2147/IJN.S79489.", "ArticleIdList": ["10.2147/IJN.S79489", "PMC4636172", "26586942"]}, {"Citation": "Sperrin M., Thygesen H., Su T.-L., Harbron C., Whitehead A. Experimental Designs for Detecting Synergy and Antagonism between Two Drugs in a Pre-Clinical Study. Pharm. Stat. 2015;14:216\u2013225. doi: 10.1002/pst.1676.", "ArticleIdList": ["10.1002/pst.1676", "25810342"]}, {"Citation": "Conti L., Lanzardo S., Ruiu R., Cadenazzi M., Cavallo F., Aime S., Crich S.G. L-Ferritin Targets Breast Cancer Stem Cells and Delivers Therapeutic and Imaging Agents. Oncotarget. 2016;7:66713\u201366727. doi: 10.18632/oncotarget.10920.", "ArticleIdList": ["10.18632/oncotarget.10920", "PMC5341832", "27579532"]}, {"Citation": "Malekzadeh A.M., Ramazani A., Rezaei S.J.T., Niknejad H. Design and Construction of Multifunctional Hyperbranched Polymers Coated Magnetite Nanoparticles for Both Targeting Magnetic Resonance Imaging and Cancer Therapy. J. Colloid Interface Sci. 2017;490:64\u201373. doi: 10.1016/j.jcis.2016.11.014.", "ArticleIdList": ["10.1016/j.jcis.2016.11.014", "27870961"]}, {"Citation": "Usman M., Hussein M., Kura A., Fakurazi S., Masarudin M., Ahmad Saad F. Graphene Oxide as a Nanocarrier for a Theranostics Delivery System of Protocatechuic Acid and Gadolinium/Gold Nanoparticles. Molecules. 2018;23:500. doi: 10.3390/molecules23020500.", "ArticleIdList": ["10.3390/molecules23020500", "PMC6017407", "29495251"]}, {"Citation": "Zhang Y., Garc\u00eda-Gabilondo M., Rosell A., Roig A. MRI/Photoluminescence Dual-Modal Imaging Magnetic PLGA Nanocapsules for Theranostics. Pharmaceutics. 2019;12:16. doi: 10.3390/pharmaceutics12010016.", "ArticleIdList": ["10.3390/pharmaceutics12010016", "PMC7023350", "31877821"]}, {"Citation": "Singh P., Pandit S., Mokkapati V.R.S.S., Garg A., Ravikumar V., Mijakovic I. Gold Nanoparticles in Diagnostics and Therapeutics for Human Cancer. Int. J. Mol. Sci. 2018;19:1979. doi: 10.3390/ijms19071979.", "ArticleIdList": ["10.3390/ijms19071979", "PMC6073740", "29986450"]}, {"Citation": "Miao W., Shim G., Lee S., Lee S., Choe Y.S., Oh Y.-K. Safety and Tumor Tissue Accumulation of Pegylated Graphene Oxide Nanosheets for Co-Delivery of Anticancer Drug and Photosensitizer. Biomaterials. 2013;34:3402\u20133410. doi: 10.1016/j.biomaterials.2013.01.010.", "ArticleIdList": ["10.1016/j.biomaterials.2013.01.010", "23380350"]}, {"Citation": "Wu L.-P., Wang D., Li Z. Grand Challenges in Nanomedicine. Mater. Sci. Eng. C. 2020;106:110302. doi: 10.1016/j.msec.2019.110302.", "ArticleIdList": ["10.1016/j.msec.2019.110302", "31753337"]}, {"Citation": "Zou M.-Z., Liu W.-L., Li C.-X., Zheng D.-W., Zeng J.-Y., Gao F., Ye J.-J., Zhang X.-Z. A Multifunctional Biomimetic Nanoplatform for Relieving Hypoxia to Enhance Chemotherapy and Inhibit the PD-1/PD-L1 Axis. Small. 2018;14:1801120. doi: 10.1002/smll.201801120.", "ArticleIdList": ["10.1002/smll.201801120", "29882235"]}, {"Citation": "Donoso-Quezada J., Guajardo-Flores D., Gonz\u00e1lez-Valdez J. Enhanced Exosome-Mediated Delivery of Black Bean Phytochemicals (Phaseolus Vulgaris L.) for Cancer Treatment Applications. Biomed. Pharmacother. 2020;131:110771. doi: 10.1016/j.biopha.2020.110771.", "ArticleIdList": ["10.1016/j.biopha.2020.110771", "33152932"]}, {"Citation": "Zhao S., Huang M., Yan L., Zhang H., Shi C., Liu J., Zhao S., Liu H., Wang B. Exosomes Derived from Baicalin-Pretreated Mesenchymal Stem Cells Alleviate Hepatocyte Ferroptosis after Acute Liver Injury via the Keap1-NRF2 Pathway. Oxid. Med. Cell. Longev. 2022;2022:8287227. doi: 10.1155/2022/8287227.", "ArticleIdList": ["10.1155/2022/8287227", "PMC9334037", "35910831"]}, {"Citation": "Du J., Wan Z., Wang C., Lu F., Wei M., Wang D., Hao Q. Designer Exosomes for Targeted and Efficient Ferroptosis Induction in Cancer via Chemo-Photodynamic Therapy. Theranostics. 2021;11:8185\u20138196. doi: 10.7150/thno.59121.", "ArticleIdList": ["10.7150/thno.59121", "PMC8344009", "34373736"]}, {"Citation": "Brar G., Greten T.F., Graubard B.I., McNeel T.S., Petrick J.L., McGlynn K.A., Altekruse S.F. Hepatocellular Carcinoma Survival by Etiology: A SEER-Medicare Database Analysis. Hepatol. Commun. 2020;4:1541\u20131551. doi: 10.1002/hep4.1564.", "ArticleIdList": ["10.1002/hep4.1564", "PMC7527688", "33024922"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "4", "Day": "10"}, {"Year": "2023", "Month": "5", "Day": "19"}, {"Year": "2023", "Month": "5", "Day": "22"}, {"Year": "2023", "Month": "6", "Day": "28", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "6", "Day": "28", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "6", "Day": "28", "Hour": "1", "Minute": "36"}, {"Year": "2023", "Month": "5", "Day": "29"}], "PublicationStatus": "epublish", "ArticleIdList": ["37376061", "PMC10302838", "10.3390/pharmaceutics15061611", "pharmaceutics15061611"]}}], "PubmedBookArticle": []}